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ABSTRACT 
 
BAdV-3, like many other members of the family Adenoviridae, has been developed and 
evaluated as a vaccine delivery vehicle in cattle (Ayalew et al., 2014). However, protective immune 
responses using recombinant BAdV-3 based vaccines are achieved after two immunizations (Kumar et 
al., 2014; Zakhartchouk et al., 1999). One way to increase the efficiency of BAdV-3 based vectors is by 
increasing the transduction to antigen presenting cells (APCs). Since C-terminus of BAdV-3 minor capsid 
protein pIX is exposed to the exterior of virion capsid, efforts have been made to use it to add targeting 
ligands, so that recombinant BAdV-3 expressing chimeric pIX can be targeted to a particular cell 
(Zakhartchouk et al., 2004).  
In the present study, we constructed and characterized a recombinant BAdV-3, designated as 
BAV888, expressing chimeric minor capsid protein pIX fused to RGD. The RGD motif, which is not 
present in the BAdV-3 virion, is an important pathway for the internalization of the virus into integrin-
positive cells, such as APCs. 
In vitro studies have demonstrated that at MOI 1, both BAV888 and BAV304a (BAdV-3 
expressing GFP inserted in E3 region of the genome) can transduce PBMCs without a significant 
difference in the percentage of cells transduced. However, BAV888 transduced cells exhibited a mean 
fluorescence intensity significantly higher than BAV304a transduced cells.  
Further, analysis in different PBMC subpopulations (T-cells, B-cells, monocytes, NK-cells and 
dendritic cells) showed that BAV888 and BAV304a have tropism mainly for monocytes and NK-cells. 
Furthermore, the mean fluorescence intensity of GFP+ monocytes is up to four times higher in BAV888-
transduced cells, suggesting that our recombinant virus is more efficiently internalized by monocytes. To 
prove this, we compared viral copy number of transduced monocytes and transcriptional analysis of viral 
proteins using qPCR. The copy number of BAV888 is significantly higher than BAV304a in transduced 
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monocytes at the same MOI. Moreover, the expression of GFP and early and late viral proteins is higher 
in BAV888 transduced monocytes.  
 To determine the expression of costimulatory molecules in BAV888 and BAV304a transduced 
monocytes, flow cytometry, and transcriptional analyses were performed. Although there is no significant 
difference in the expression of MHC class I and MHC class II between viruses using flow cytometry, 
analysis of the mRNA expression of showed a decrease in CD40 and CD86 expression in BAV888-
transduced monocytes compared to BAV304a and mock transduced cells.   
In terms of cytokine production, BAV888-transduced monocytes show an increased production of 
TNFα and IL-12, compared to BAV304a	 transduced monocytes. In mRNA analysis, there was a 
significant increase in expression of IFNβ in BAV888-transduced monocytes relative to BAV304a-
transduced and mock cells, which could suggest an anti-viral response against the virus.  
Our results demonstrate that, although there is no change in tropism of the virus, the addition of 
an RGD motif in the C-terminus of pIX of BAdV-3 can increased its uptake in PMBCs and, in particular, 
monocytes.  
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1. LITERATURE REVIEW  
 
1.1 Adenoviruses  
In 1953, Wallace Rowe noticed changes in epithelial cells morphology after incubating adenoids from 
infants, followed by the destruction of the tissue days later (Rowe et al., 1953). Hilleman and Werner had 
similar findings while investigating an outbreak of an acute respiratory illness, claiming that they found a 
novel viral agent, which they called “RI-67” (Hilleman and Werner, 1954). Later on, with isolates from 
RI-67 in conjunction with sera from patients with a syndrome called “acute respiratory disease (ARD)”, 
Ginsberg found evidence that ARD syndrome might be caused by a complex mixture of pathogens, 
including RI-67, which they proposed to call “ARD virus” (Ginsberg et al., 1955). 
Huebner named a new group of respiratory viruses as “adenoidal-pharyngeal-conjunctival agents” 
based on the symptomatology and anatomical areas from where these viruses could be isolated. Although 
they describe six types based on results from immunology tests, all cause the same cytopathogenic effects 
in the epithelium (Huebner et al., 1954). Later, Rowe et al. found eight new serologically distinct types 
from the ones previously described, for a total of 14 serotypes for the “adenoidal-pharyngeal-
conjunctival” group of viruses. All these viruses possess similar characteristics including sharing a 
complement-fixing antigen and producing similar cytopathogenic effects (Rowe et al., 1956).  Cells 
infected with adenovirus present similar characteristics, such as cellular aggregation and rounding, and 
nuclear inclusions (Harrach, 2008). 
The term “Adenovirus” was proposed for the group of viruses isolated primarily from adenoids, 
which share common characteristics such as producing infection of ocular and respiratory epithelium, a 
distinctive cytopathogenic effect in cell culture, sharing a common antigen in the complement-fixation 
test all without causing visible disease in laboratory animals (Enders et al., 1956).  
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1.1.1 Adenovirus taxonomy and biology 
The host range of adenovirus is narrow, restricted to one or a few usually closely related species.  
Most human adenoviruses (HAdV) infect humans, without producing any clinical sysmptoms but some 
HAdV types are associated with respiratory, ocular or venereal disease. HAdV is one of the primary 
causes of diarrhea in young children and can be transmitted through ocular and throat secretions, feces 
and urine. In mammals, infections by adenoviruses are common, but usually subclinical, unless the 
animals are under stress or immunocompromised. The only exception is Canine adenovirus 1(CAdV-1) 
that can cause fatal disease in young and wild animals; and CAdV-2, which causes very contagious 
respiratory infections in domestic dogs (King et al., 2011).  
 
1.1.1.1 Adenovirus classification 
The family Adenoviridae is composed of five genera: Mastadenovirus, Aviadenovirus, Atadenovirus, 
Siadenovirus, and Ichtadenovirus. Recently, a sixth genus, Testadenovirus, is proposed to include 
adenoviruses from turtles (Order Testudin) (Doszpoly et al., 2013). These genera can be differentiated 
using the complement fixation assay, where every genus reacts to a specific antigen, and there is an 
evident separation of each cluster in phylogenetic analyses (Fig.1.1) (King et al., 2012).   
The genus Mastadenovirus is composed of more than 20 species that infect mammals only. The 
size of the genomes of Mastadenovirus members ranges between 30.2 to 38kb, with longer and more 
complex ITRs than other genera in the Adenoviridae family (Harrach, 2008). Several polypeptides 
encoded by early regions E1A, E1B, E3 and E4, minor capsid protein IX and core protein V are unique to 
members of this genus. Except proteins encoded by E3 and E4 regions, most of its genome is conserved 
in all mastadenoviruses. Human adenovirus C is the most studied species in the genus (King et al., 2011; 
Vrati et al., 1995).  
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Members of Aviadenoviruses infect only birds. Morphologically, they differ from other genera 
because they possess two fibers on each penton base (Chiocca et al., 1996; Marek et al., 2014). Although, 
they are known for causing diverse symptoms in bird species, mainly in the respiratory system 
(pulmonary congestion and bronchitis), they can also induce abnormalities in liver, heart and egg 
production (Benkő, 2008; Hess et al., 1997). Their genome size ranges - between 43.8 and 46.6kb. These 
viruses contain unique transcription units at one of the extremes of their genome, but the gene content in 
this region has not been well studied (King et al., 2011). 
The genus Atadenovirus received its name because of a unique characteristic: its DNA has a high 
A+T content, up to 66% in some species. Compared to other genera, members of this genus can infect a 
broader range of species including ruminants, marsupials, birds, and reptiles (Harrach, 2008). Most 
members of Atadenovirus do not cause severe disease, even though an outbreak of Odocoileus adenovirus 
killed a large population of deer in North America. Virions are less sensitive to heat compared to other 
adenoviruses and have unique essential structiural proteins like p32k and LH3 (ÉlŐ et al., 2003; Gorman 
et al., 2005).  
Members of Siadenovirus genus include frog adenovirus 1, turkey adenovirus 3 and raptor 
adenovirus 1 and contain the shortest genomes of all adenoviruses, between 26.1 and 26.2kb (Kovács and 
Benkő, 2009; Pitcovski et al., 1998). Member of Ichtadenovirus genus include white sturgeon adenovirus 
1, a non-pathogenic virus, which infect fish. It contains the longest genome (48.3 kb) identified in 
members of adenoviridae family (Kovács et al., 2003).		
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Figure 1.1 Phylogenetic analysis of family Adenoviridae. Reproduced with permission from Fig. 5 in 
(King et al., 2012) Family – Adenoviridae. Place: Elsevier.  
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1.1.1.2 Virion structure  
Adenovirus virions are non-enveloped, possess icosahedral symmetry, and their capsid is formed 
by 240 hexons and 12 penton bases and fibers (Harrach, 2008). One-third of the almost 50 different 
polypeptides encoded by the DNA of the virion correspond to capsid proteins (Acheson, 2011), which are 
usually conserved in all genera, except for protein V and IX, that can be only found in members of the 
Mastadenovirus genus (King et al., 2011).  
Hexons (trimers of polypeptide II) are considered major capsid proteins; they are firmly arranged 
together, forming a protective shell for inner proteins and nucleic acids (Leppard, 2008). Hexons contain 
conserved regions and hypervariable regions (HVRs) in their sequence; interesingly, the latter ones do not 
seem to interact with any other viral protein (Crawford-Miksza and Schnurr, 1996). However, HVRs have 
been found to contain serotype-specific epitopes (Rux and Burnett, 2000).  
The penton base is a bucket-shaped structure, with a fiber shaft emerging from its center (Ruigrok 
et al., 1990). Its sequence is highly conserved between adenoviruses, and in most cases they contain an 
RGD motif (Zubieta et al., 2005). 
There is one fiber per penton base, constituted by several polypeptides IV and III at each vertex 
(Leppard, 2008; Steward et al., 1993; van Oostrum and Burnett, 1985). Despite their structural functions, 
fibers are essential for attachment to the cell, which constitutes the first step in viral infection 
(Chroboczek et al., 1995).  
The group of minor capsid proteins is constituted by IIIa, VIII, IX, and VI that maintain the 
hexon proteins in the capsid together (King et al., 2011; Acheson, 2011). Protein IX is the smallest of 
them and it is only present in the genus Mastadenovirus (Everitt and Philipson, 1974). The N-terminus of 
the protein is inside the virion, between the hexons, while the C-terminus faces the exterior of the capsid 
(Akalu et al., 1999). Each facet of the virion contains twelve pIX molecules which are not essential for 
the virus but provide stability to the capsid at high temperatures (Boulanger et al., 1979; Colby and 
Shenk, 1981; Furcinitti et al., 1989; Rosa-Calatrava et al., 2001). Crystallography studies of adenovirus 
virions confirm that pIX interacts primarily with the hexons, and form triskelion structures (Natchiar et 
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al., 2018). The N-, C- terminus and a central alanine-rich portion are conserved between serotypes, but 
the N-terminus is only responsible for capsid insertion (Rosa-Calatrava et al., 2001; Vellinga et al., 
2005). Protein IX can also affect the capacity of the virus to package its DNA (Ghosh-Choundry et al., 
1987) and has the ability to stimulate several promoters (Lutz et al., 1997).  
Protein VIII structure is generally well-conserved among adenoviruses (Yu et al., 2017). It 
contains motifs recognized by adenoviral protease (AVP) (Liu et al., 2010). The protease cleavage 
appears essential for maturation of progeny virus (Gaba et al., 2017). To hold the hexons together, pVIII 
interacts with pIIIa forming cementing interactions (Natchiar et al., 2018).  
The capsid protein pIIIa (Benevento et al., 2014) is a cement protein, located beneath the vertex 
region in the interior of the viral capsid (Natchiar et al., 2018). To hold the hexons together, pVIII 
interacts with pIIIa forming cementing interactions (Natchiar et al., 2018). Protein IIIa is also involved in 
determining the serotype specificity of adenovirus DNA packaging (Ma and Hearing, 2011). Protein pIIIa 
appear to be cleaved by adenovirus protease, which is potentially essential for the maturation of progeny 
virus (Gaba et al., 2017). 
The capsid protein pVI is involved in nuclear localization and assembly of hexons in nucleus 
through interaction of N -terminus of pIV with hexons (Moyer et al., 2015; Natchiar et al., 2018). Protein 
pIV is cleaved by adenovirus protease,  which appears essential for virus entry and capsid assembly 
(Moyer et al., 2015). In addition, while C-terminal factor acts as a co-factor for adenovirus protease 
cleavage of selected adenovirus proteins, the lytic region of N-terminal fragment appears to be involved 
in endosome lysis during intial stages of virus infection (Mangel et al., 1993 Wiethoff et al., 2005; 
Luisoni et al., 2015). 
Mastadenovirus genus specific polypeptide V is also part of the core proteins, and it interacts 
with protein VI, facing the interior of the capsid, and the dsDNA (Flint, 2016). pV also associates with 
the host cell nucleoli (Matthews and Russel, 1998). It contains multiple nuclear and nucleolar localization 
signals, and it can redistribute major nucleolar proteins to the cytoplasm (Matthews, 2001). 
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Protein VII, the most abundant core protein in the virion, is tightly associated with the viral DNA 
(Benevento et al., 2014). In the early phases of viral infection, pVII remains associated with the 
adenoviral DNA (Walkiewicz et al., 2009), but it is released when the transcription of early genes is 
initiated (Chen et al., 2007). A recent report suggests that pVII is not required for DNA condensation,, 
DNA packaging or virion assembly, but appears vital for the viral escape from the endosome in early 
stages of infection (Ostapchuk et al., 2017).  
Mu is a 9 kDa protein and is present between 100 and 300 copies per virion (Anderson et al., 
1989). Like protein VII, during maturation mu is cleaved by the viral protease (Blainey et al., 2013). 
Proteins V, VII and mu interact with each other in the viral core (Chatterjee et al., 1985) and with the 
viral dsDNA, neutralizing its negative charge to allow its condensation and tight packaging within the 
icosahedral capsid (Pérez-Berná et al., 2015).  
The Terminal protein (TP) is essential for the virus since it primes its genome replication (Liu et 
al., 2003) . It is cleaved by adenovirus protease before maturation of progeny virus (Webster et al., 1997). 
The genome of adenoviruses is linear, double-stranded DNA (dsDNA), with a TP at the 5’ end of 
each strand (Acheson, 2011), and contains inverted terminal repeat (ITR) sequences with variable sizes, 
between 36 to more than 200 bp (Davison et al., 2003). The middle region is conserved among the 
different genera in the family, while the 5’ and 3’ ends vary in composition and dimension. The genomes 
of members of adenoviridae family range in size from 26,163 to 48,395 bp (King et al., 2011). Many 
adenoviral genes are spliced in both conserved and non-conserved regions (Harrach, 2008). 
Virions are stable at freezing temperatures, and their heat sensitivity is variable, depending on the 
genera (Harrach, 2008). They are resistant to mild acid and cannot be inactivated using lipid solvents, 
because of their lack of envelope (Leppard, 2008). 
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Figure 1.2 Adenoviral structure. Reproduced with permission from Fig. 5 in (Leppard, 2008). 
Adenoviruses: Molecular Biology. Place: Elsevier.  
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1.1.1.3 Virus life cycle  
Adenoviruses interact primarily with the cell-surface protein (e.g coxsackie-adenovirus receptor 
[CAR] for HAdV-5) through adenovirus fiber knob (Bergelson, 1999; Nemerow et al., 2009). However, 
there are other receptors that a may be involved in the adenovirus primary attachment to the cell, such as 
CD46, CD80/CD86, MHC I α-2, heparan sulfate proteoglycans (HSPG), and vascular cell adhesion 
molecule 1 (VCAM-1) (Defer et al., 1990; Hong et al., 1997; Dechecchi et al., 2000; Chu et al., 2001; 
Short et al., 2004). Once the primary attachment has occurred, integrins αvβ3 and αvβ5, present in the cell 
surface, interact with the Arg-Gly-Asp (RGD) motif located in the viral penton base, allowing the virus 
internalization via receptor-mediated endocytosis (Wickham et al., 1993). 
The virus enters the cell through endocytosis (Meier and Greber, 2004; Varga et al., 1991), and 
the consequent acidification of the vesicle leads to loss of some proteins of the virion, like fiber and pVI 
(disassembly), which is vital to complete the viral cycle (Moyer et al., 2016). This process is responsible 
for the lysis of the membrane of the endosome and the release of the virion in the cytoplasm of the cell 
(Wiethoff et al., 2005). Recent report suggest that pVI binds to the endosome membrane, resulting in a 
positive curvature that leads to fragmentation of the endosome and release of the viral particle to the 
cytoplasm (Maier et al., 2010)  
Once in the cytoplasm, the viral genome is transported to the nucleus with the aid of microtubules 
and dynein (Leopold et al., 2000; Bremner et al., 2009; Kelkar et al., 2006; Zhou et al., 2018). Finally, 
the adenovirus protein hexon associates with nucleoporin Nup214 outside the nuclear pore complex 
(Cassany et al., 2015), which helps to finally disrupt the capsid and transport the adenovirus genome to 
the nucleus. 
Transcription of the entire viral genome occurs in the nucleus is mostly facilitated by the host 
enzyme RNA polymerase II. The gene expression is temporally regulated by viral and host proteins that 
activate specific regions of the adenovirus genome (Leppard, 2008). Early regions, E1 to E4, encode 
proteins: a) responsible for modulating the transcription of viral DNA using the host machinery, b) help to 
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avoid the detection of virus infection by host immune response immune, and c) required for DNA 
replication. The intermediate and late regions encode proteins involved in virion assembly and production 
of infectious progeny virions (Harrach, 2008).  
At the beginning of the infection, the E1A region is the first one to be transcribed. It encodes two 
proteins, 286R and 243R, that are known for regulating the host cell-cycle to allow viral replication, and 
acting as transcription activators for the early gene promoters (Avvakumov et al., 2002; Crisostomo et al., 
2017). The early region E1B encodes two proteins, 19K and 55K, which suppress apoptosis (Debbas and 
White, 1993).  
The E2 region encodes proteins required for DNA replication including DNA polymerase (DNA 
pol), DNA-binding protein (DBP), and terminal protein precursor (pTP) (de Jong et al., 2003).  
Early region E3 encodes proteins that are not essential for viral replication, but mainly regulate 
the host immune responses (Orwitz, 2004). Proteins encoded by the E4 region of the viral genome have a 
variety of functions in different cellular and viral processes such as apoptosis, transcription, control of the 
cell cycle and regulation of the host innate antiviral response (Täuber and Dobner, 2001; Ullman and 
Hearing, 2008). 
The accumulation of DBP, DNA pol, and pTP is a signal to start viral DNA replication. 
Replication of the genome does not require the host DNA helicase, and elongation is reliant on the viral 
DBP (Dekker et al., 1997). The origin of replication of this virus is situated at the extremes of the 
genome, within the ITR regions. DBP has an important role again because it can modify the conformation 
of the origin of replication, which enhances the ability of the DNApol to bind to it (Lindebaum et al., 
1986; van Breukelen et al., 2003). After the assembly of a pre-initiation complex (PIC), which includes 
the viral proteins pTP DNApol and DBP, and cellular proteins such as NFI and NFIII, pTP serves as a 
primer to start the replication, where the DNApol has both polymerase (5’ to 3’) and exonuclease activity 
(3’ to 5’) (Bosher et al., 1990; Challberg et al., 1980; Mul et al., 1990; Nagata et al., 1983). 
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The DNA replication marks the transition between the expression of early and late genes of the 
adenovirus genome. Proteins IVa2 and pIX are considered intermediate genes, and they get activated 
when DNA replication is initiated. Protein IVa2 has very important roles in the viral life cycle since it 
participates in the activation of the major late promoter (MLP) and packaging of the virion (Lutz and 
Kedinger, 1996; Pardo-Mateos and Young, 2004; Tribouley et al., 1994; Zhang and Imperiale, 2003). On 
the other hand, protein IX is a small polypeptide that holds hexon proteins together in the viral capsid, 
increasing its stability and has also been shown to stimulate the MLP activity (Boulanger et al., 1979; 
Lutz et al., 1997). After DNA replication, the late region of adenovirus genome is transcribed as a single 
transcript using the major late promoter, which produces overlapping transcripts based on use of different 
poly A signals, additional sites, and alternate splicing (Backström et al., 2010; Ziff and Evans, 1978). 
These overlapping transcripts encode both structural and non-structural proteins. Although viral capsid 
proteins are synthesized in the cytoplasm of the infected cell, the assembly of the virus takes place in the 
nucleus, where progeny genomes are produced (Velicer and Ginsberg, 1970). The non-strutural 100K 
viral protein is responsible for assembly of the hexons trimers (Cepko and Sharp, 1982; Shah et al., 
2017). Next step is the encapsidation of the DNA in the capsids, which requires a cis acting signal(s) 
located at the left end of its genome (Hammarskjöld and Winberg, 1980; Hearing et al., 1987). Several 
viral (IIIa, 52k, 22k, IVa2) and cellular proteins are involved in interacting with genome packaging DNA 
sequences to encapsidate adenovirus genome in empty capsids. (Ma and Hearing, 2011; Ostapchuk et al., 
2011; Guimet and Hearing, 2013; Wu et al., 2013). Recent reports suggest that capsid formation and 
DNA encapsidation may occur simultaneously (Condezo and San Martín, 2017). 
Once the genome is packaged inside the capsid, next step is the removal of non-structural proteins 
(52 K, 22 K, 33 K, 100 K). Recent studies have shown that the mechanism of cleavage of one of these 
proteins, NS 52 K, is DNA dependent and it causes the disruption of the interaction with this protein and 
other capsid and core proteins, which results in the absence of 52K in mature virions (Pérez-Berná et al., 
2014). Finally, maturation of progeny virions is associated with cleavage of capsid and core precursor 
proteins (pIIIa, pVII, pVIII, pX 52K, and pTP) by adenovirus protease (Mangel and San Martin, 2014). 
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Recent reports have suggested that cleavage of pVIII (Gaba et al., 2017) and pVI (Moyer et al., 2017) 
appear essential for production of infectious progeny virions. 
Finally, mature virions are released by cell lysis, with the aid of the Adenovirus death protein 
(ADP) (Tollefson et al., 1996).  
 
1.1.2 Bovine adenovirus  
In 1959, viral isolates from apparently healthy cattle were found to share antigenic properties 
with human adenoviruses (Klein et al., 1959). Recent reports suggest that bovine adenoviruses are present 
in high percentages in bovine population and can be detected in cattle feces, urine and, even in soil/water 
in feedlots and residential areas (Sibley, 2011).  
 
1.1.2.1 Classification of Bovine Adenoviruses 
Bovine adenoviruses belong to two different genera: Mastadenovirus (BAdV-1, -2, -3, -9 and -
10) and are Atadenovirus (BAdV-4, -5, -6, -7 and -8). BAdV-1, -2, -3 and -9 are known for growing well 
in vitro and for cross-reacting in complement fixation tests, while members of subgroup 2 (BAdV-4, -5, -
6, -7, -8 and -10) are harder to propagate in cell cultures and do not have any cross-reactivity with other 
mammalian adenoviruses antibodies (Bartha, 1969; King et al., 2011).  
  
1.1.2.2 Genome organization of BAdV-3 
The complete genome of BAdV-3 is 34,446 bp in length, and possesses a G+C content of 54%; 
similar to other members of Mastadenovirus, BAdV-3 genome can be divided into early, intermediate and 
late regions (Fig. 1.3) (Reddy et al., 1998).  
The E1 region is located at the left end of the genome which is divided into E1A and E1B (Reddy 
et al., 1999) sharing a common poly(A) site along with pIX (Zheng et al., 1994; Zheng et al., 1999). The 
E1A region is the first to be transcribed and produces three small non-structural proteins, which have a 
role in BAdV-3 replication and activation of viral genes (Reddy et al., 1999; Zheng et al., 1999; Zhou et 
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al., 2001b). In contrast, the E1B region encodes two overlapping mRNAs: E1Bsmall and E1Blarge (Reddy et 
al., 1999) The E1Bsmall and E1Blarge expresses a 19 kDa and 48 kDa protein, respectively in BAdV-3 
infected cells (Reddy et al., 1999). While E1Blarge 48 kDa protein appears essential for virus replication, 
E1Bsmall 19 kDa protein appear essential for virus replication only in certain cells (Zhou et al., 2001b).  
Early (E) region 2 is composed of E2A and E2B regions and contain genes required for DNA 
replication (Reddy et al. 1998). DBP (DNA binding protein) encoded by E2A region is expressed as a 50 
kDa protein from 6 hrs to 48 hrs post infection (Reddy et al., 1998; Zhou et al., 2001a). The detection of 
DBP in BAdV-3 infected cells using immunohistochemical methods can be used for titration of the virus 
(Zhou et al., 2001a). On the other hand, early region 2B encodes a terminal protein precursor (pTP) and 
the viral DNA polymerase (Baxi et al., 1998).  
Region E3 appears to encode four proteins: 284R, 121R, 86R, and 82R that are not essential for 
virus replication (Idamakanti et al., 1999; Zakhartchouk et al., 1999). Protein 284R is a glycoprotein 
which does not show homology to proteins encoded by E3 region of members of other Mastadenoviruses 
(Idamakanti et al., 1999). In addition, protein 121R has been shown to inhibit apoptosis mediated by 
TNFα (Zakhartchouk et al., 2001). 
E4 region has the potential to encode five ORFs. Of these, ORF1, ORF2, and ORF4 appear 
unique to BAdV-3 (Lee et al., 1998). Mutational analysis of this region showed that none of these ORFs 
are required for viral replication (Baxi et al., 2001).  
Intermediate region encode two proteins named IVa2 and IX (Reddy et al., 1998). Protein IVa2 is 
a structural and shares up to 69% of identity with its counterparts encoded by other members of 
Matadenoviruses (Reddy et al., 1998). On the other hand, protein IX is minor structural protein which 
shares a low percentage of identity (16-28%) with homologs encoded by other members of 
Mastadenoviruses (Reddy et al., 1998; Zheng et al., 1999). Interestingly, the C-terminus of pIX, facing 
the exterior of the viral capsid, has been successfully modified to alter the tropism of the virus 
(Zakhartchouk et al., 2004), which has helped to enhance the transduction efficiency of the virus to a 
wider range of cells (Zakhartchouk et al., 2004). 
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The late (L) region, which encodes structural and non-structural proteins is transcribed as a single 
primary transcript using major late promoter. Subsequently, alternate splicing and usage of polyA 
addition signal produces overlapping transcripts which can be grouped into seven regions L1-L7 (Reddy 
et al., 1998). L1 region encodes proteins 52K, IIIa, III, and pVII.  
Protein 52K, a non-structural protein expressed as 40 kDa protein, which localizes to nucleus 
using nuclear localization signal and importin α-3 (Paterson et al., 2012). The 52K protein interacts with 
protein pVII and redistributes the cellular NFκB-binding protein inside the nucleus (Paterson, 2010; 
Paterson et al., 2012). It has been suggested that the interaction between NFBP and 52K could possibly 
inhibit the cellular processing of rRNA and cause changes in the activity of NFκB in infected cells 
(Paterson, 2010). Moreover, 52K protein localizes to mitochondria using mitochondria localization 
signals (MLS), which coincide with an increase in ROS/SO production in transfected cells without major 
changes in mitochondrial Ca2+ or ATP production, indicating that 52K could be responsible for oxidative 
stress and apoptosis in BAdV-3 infected cells (Anand et al., 2014) 
Protein IIIa is a structural protein (Reddy et al., 1998), and appears to be involved in stabilizing 
the capsid (Vellinga et al., 2005). In addition, protein III, also recognized as penton base protein, contains 
an “RGD” motif which is shown to be involved in adenovirus internalization and viral entry into the cell 
(Wickham et al., 1994). However, BAdV-3 penton base protein contains “MDV” motif instead of “RGD” 
motif, which suggests that BADV-3 may use an alternate mode of virus entry (Reddy et al., 1998).  
Protein VII is localized in the core of the virus, and its sequence contains a protease cleavage site 
(Reddy et al., 1998) suggesting at pVII may be cleaved by adenovirus protease. Recent study has shown 
that pVII localizes to the mitochondria using a mitochondrial localization signal localized at the N-
terminus of pVII (Anand et al., 2014). pVII appears to modulate the mitochondrial activity of the infected 
cell and inhibits apoptosis (Anand et al., 2014). 
Protein V is a structural protein (Reddy et al., 1998) which appears essential for maintaining the 
integrity of BAdV-3 virion capsids and production of infectious virions (Zhao and Tikoo, 2016). Protein 
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pV localizes to nucleus using three nuclear localization signals and importin α3 (Zhao 2016). pV also 
contains two nucleolar localization signals, which appear essential for production of progeny virions 
(Zhao, 2016). 	
L3 and L4 regions encode just one protein each: protein X and VI, respectively (Reddy et al., 
1998). The protein X of BAdV-3 is rich in basic amino acids, and it contains one nuclear localization 
signal and two protein cleavage sites, which suggests that it is cleaved by the viral protease (Reddy et al., 
1998). pVI is a structural protein, and it contains two consensus sequence motifs for cleavage by 
endoproteases (Reddy et al., 1998). Although its function is not well understood in BAdV-3, the 
precursor of this protein has been related to transport of hexon capsomers to the nucleus in HAdV 
(Kauffman and Ginsberg, 1976). 
The L5 region of BAdV-3 encodes the hexon protein and a protease (Reddy et al., 1998). Hexon is a 
major component of the capsid, and it is a potent adjuvant for activation of cell-mediated immunity in 
HAdV (Molinier-Frenkel et al., 2002). The protease is essential for the attainment of infectious virions 
since many viral protein precursors need to be cleaved by this protein for maturation (Cai et al., 1990; 
Reddy et al., 1998). 
Non-structural proteins 100K, 33K, and 22K, together with the structural protein pVIII are 
encoded in L6 region of the BAdV-3 genome (Reddy et al., 1998). The 100K protein is localized in the 
cytoplasm and nucleus of infected cells (Makadiya et al., 2015) and it interacts with protein 33K 
(Kulshreshtha and Tikoo, 2008). Although cleavage by viral protease is required for nuclear localization 
of 100K in BAdV-3 infected cells, this is not essential for replication (Makadiya et al., 2015). 33K and 
22K are produced by alternative splicing of a single transcript and share the same N-terminal 
(Kulshreshtha et al., 2015). 33K plays a major role in the activation of the major late promoter 
(Kulshreshtha et al., 2015), while protein 22K appears to be necessary for viral replication (Kulshreshtha 
et al., 2004).  
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Figure 1.3 Schematic representation of Bovine Adenovirus-3 genome. Reproduced with permission from 
Fig. 1 in (Reddy et al., 1998).	Nucleotide Sequence, Genome Organization, and Transcription Map of 
Bovine Adenovirus Type 3. Place: American Society for Microbiology.  
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Minor structural protein VIII is localized in the nucleus of infected cells and interacts with 
importin α3 (Ayalew et al., 2014), and its two protease cleavage sites are vital for replication (Gaba et al., 
2017).  
Finally, the L7 region encodes the fiber protein, which is long and bent in BAdV-3 virions 
(Ruigrok et al., 1994).,  The knob region of fiber is involved in the initial attachment to host cell receptor, 
and interacts initially with cellular receptor (sialic acid) (Bangari et al., 2005). The fiber protein is 
expressed as 102- kDa protein in infected cells (Wu and Tikoo, 2004). The fiber protein is localized to the 
nucleus of infected cells using nuclear localization signal (amino acids 14-20) and fiber protein seems 
essential for the successful replication of the virus (Wu and Tikoo, 2004). 
 
1.1.2.3 Viral attachment and internalization  
The primary interaction between the viral particle and the cell is through the attachment of virion 
using knob region of fiber to a cell surface receptor. For instance, in HAdV-5, the fiber knob interacts 
with Coxsackievirus-adenovirus receptor (CAR) in the cell (Bergelson et al., 1997), followed by a 
secondary interaction between the penton base of the virus and integrins in the surface of the cell (Sharma 
et al., 2009). In contrast, BAdV-3 does not interact with CAR for attachment to the cell, but it uses sialic 
acid as a primary receptor instead (Bangari et al., 2005; Li et al., 2009). Moreover, due to the lack of an 
RGD motif in its capsid, it does not utilize the integrin pathway for internalization (Reddy et al., 1998). 
Interestingly, BAdV-3 penton protein contain “MDV” motifs instead (Reddy et al., 1998). Although little 
has not been reported regarding different steps of BAdV-3 replication, it appears that once internalized, 
BAdV-3 replication follows steps similar to HAdV-5 (Flint et al., 2009).  
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Level of relative 
transduction 
Cell line Species Origin CAR expression  
 
 
 
 
 
Higher than  
HAdV-5 (≥101%) 
Jurkat Human T cell leukemia Below detection level 
NIH 3T3 Murine Mouse fibroblast Below detection level 
FBRT HE1 Bovine Fetal retina transformed with 
HAdV-5 E1 
High 
MDBK Bovine Kidney High 
FBK-34 Bovine Kidney transformed with 
BAdV-3 E1 
High 
BT-5705 Bovine Turbinate Below detection level 
EBL Bovine Embryonic lung Below detection level 
PK-15 Porcine Kidney High 
PT-K75 Porcine Turbinate Below detection level 
SBC-1765 Porcine Derived from buffy coat cells Below detection level 
EPL Porcine Embryonic lung Below detection level 
 
 
 
 
High (50-100%) 
293 Human Embryonic Kidney High 
MTIA2 Murine Mammary tumor transformed 
with SV40 T antigen 
High 
WEHI Murine Fibrosarcoma Below detection level 
EL4 Murine T cell High 
FPRT 
HE1-5 
Porcine Fetal retina transformed with 
HAdV-5 E1 
High 
PK-M12 Porcine Kidney cell transformed with 
SV40 T antigen 
Moderate 
 
Moderate (25-49%) 
MCF-10A Human Mammary epithelium Moderate to low 
AML12 Murine Liver Below detection level 
MS-K68 Murine Spleen Moderate 
 
   
   Low (15-24%) 
MDA-MB-
231 
Human Malignant breast cancer cell Moderate to low 
PC-3 Human Prostate cancer metastases site Below detection level 
LNCaP Human Prostate cancer metastases site High 
DU145 Human Prostate cancer metastases site High 
 
Very low (≤14%) 
HepG2 Human Hepatocarcinoma High 
T24 Human Transitional cell carcinoma Below detection level 
TCCSUP Human Transitional cell carcinoma Below detection level 
 
Table 1.1 Relative transduction of BAdV-3 compared to HAdV-5 in cell lines from a variety of origins 
and CAR expression levels (Bangari et al., 2005). 
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1.1.2.4 Tropism  
The tropism of HAdV-5, the most studied adenovirus, is thought to be mostly dependent on the 
expression of the coxsackie-adenovirus receptor (CAR) in the cell surface; therefore, cells lines 
expressing a high quantity of CAR will be transduced more efficiently by HAdV-5 (Bergelson et al., 
1997). 
BAdV-3 tropism is independent of CAR, which explains its ability to efficiently transduce even 
CAR-deficient cells. Although BAdV-3 transduces bovine and porcine cells, human cells are poorly 
transduced (Table 1.1) (Bangari et al., 2005; Rasmussen et al., 1999; Wu and Tikoo, 2004). 
 
1.2 Bovine immune system  
The immune system in cattle is composed of different tissues and organs: the thymus, spleen and 
lymph nodes (Suleymanov, 2005). The thymus undergoes morphological and functional changes during 
the lifetime of the animal (Gazizova, 2001) and is a critical organ of the immune system (Galaktionov, 
2005). Furthermore, it has endocrine functions, producing hormones involved in the maturation of pre T-
cells into functional T-lymphocytes (Gazizova and Murzabekova, 2007; Gazizova and Atkenova, 2015). 
The central organ of the embryonic immune system, the thymus, is where lymphoid cells are formed and 
mature, and where the processes that occur in the peripheral lymphoid organs, spleen, and lymph nodes, 
are regulated in the early stages of life in calves (Drannik, 2003). As the host ages,  lymphopoiesis 
decreases gradually in these organs, although some functional tissue in the thymus still remains active in 
animals of old age (Bodrova, 2010). 
In addition, Peyer’s patches constitute one of the primary sources of systemic B-cells in 
ruminants, and they serve as a major site for B-cell proliferation and antigen-independent somatic 
hypermutation of immunoglobulins (Griebel and Hein, 1996). 
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Besides the thymus and Peyer´s patches, lymphocytes are also produced in the bone marrow and 
then travel in the bloodstream until reaching peripheral lymphoid organs (Gridnev and Mironov, 2003). 
Antigenic exposure in these organs causes complex interactions between immune cells that trigger 
lymphocyte differentiation, proliferation and transformation of B and T cells into effector cells 
(Kondrakhin, 2004).  
The spleen participates in the production of IgM, synthetizes tuftsin tetrapeptide that stimulates 
NK cells, promotes phagocytosis and enhances the activity of macrophages (Kapitonov et al., 2005; 
Kierszenbaum and Tres, 2015; Lustig et al., 2007).  
The system in the bovine can be further divided into two components: the innate and the adaptive 
immunity that work together with different mechanisms to recognize and eliminate pathogens that 
threaten the animal’s health (Carroll and Forsberg, 2007). 
 
1.2.1 Innate immunity  
Contrary to the adaptive immune system which is present only in highly complex organisms such 
as vertebrates, the innate immune system is found in all multicellular organisms (Pancer and Cooper, 
2006). There is cellular, but also a humoral component in innate immunity, where proteins such as 
complement, C-reactive protein, LPS binding protein, and other antimicrobial peptides facilitate the 
clearance of the potential infection (Turvey and Broide, 2010).  
The cells involved in the innate immune system originate from from hematopoietic origins (e.g. 
dendritic cells, mast cells, macrophages, neutrophils, basophils, eosinophils and NK cells) and non-
hematopoietic origin (e. g. epithelial cells composing different organs, like the skin and gastrointestinal 
and respiratory tracts) to prevent pathogens from infecting the host (Turvey and Broide, 2010).  
 The innate immune system identifies potentially harmful elements through soluble proteins or cell 
surface receptors (Stahl, 1992). This system relies on three main strategies to recognize pathogens. The 
first example is the molecules recognized by the pattern recognition receptors, which are known as 
pathogen-associated molecular patterns (PAMPs) (Janeway, 1989). The second kind of molecules 
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recognized by the innate immune system is the damage-associated molecular patterns (DAMPs), which 
are molecules that are upregulated in tissue damage and cell lysis when inflammation and infection occur 
(Bianchi, 2007). Finally, there are certain molecules that are not expressed in infected cells or in 
pathogens, but are present in healthy cells; the innate immune system can recognize the lack of these 
molecules: for example, NK cells can detect the downregulation of MHC class I molecules in the cells 
due to an infection and attack them (Joncker and Raulet, 2008). 
 
1.2.1.1 Pattern Recognition Receptors 
The detection of pathogens through innate immunity is achieved using a variety of pattern 
recognition receptors (PRRs). Toll-like receptors (TLRs) are usually found in the plasma membrane and 
endosome (Kaisho and Akira, 2006). These receptors recruit adaptor proteins that finally activate nuclear 
factor kappa b (NF-κB), interferon regulatory factors, and other molecules that will culminate with the 
expression of a variety of cytokines, chemokines, and interferons, and interfere with the cell metabolism 
(Honda et al., 2005).  
The second class of innate sensors, known as RIG-I like receptors (RLRs), which are particularly 
important as anti-viral defenses, recognize foreign cytosolic RNA from viral origins (Yoneyama et al., 
2004) and induce the expression of type I interferons and antiviral cytokines (Kawai et al., 2005; Meylan 
et al., 2005).  
The nucleotide oligomerization domain-like receptors (NLRs) detect PAMPs and DAMPs 
(Martinon et al., 2009) and many of them are responsible for inflammatory responses after sensing 
pathogens like bacteria or viruses, activating caspase-1, that will finally lead to the activation of pro-
inflammatory cytokines IL-1β and IL-18 (Martinon et al., 2002).  
Another group of innate sensors is the C-type lectin receptors (CLRs). This group is composed of 
three members: mannose receptor (MR), Dectin-1, and dendritic cell-specific intercellular adhesion 
molecule-grabbing nonintegrin (DC-SIGN), which are all expressed in the plasma membrane of immune 
cells and recognize mainly fungal pathogens (Areschoug and Gordon, 2008). 
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In addition to TLR, RLR, NLR, and CLR receptors, there are cytosolic DNA sensors such as DAI 
(DNA-dependent activator of IFN-regulatory factors) and IFI16 that lead to the production of type I 
interferons (Takaoka et al., 2007; Tsuchida et al., 2010), and AIM2 (absent in melanoma 2) that can 
initiate the inflammasome formation, leading to the production of inflammatory cytokines such as IL-1β 
and IL-18 (Jones et al., 2010).  
 
1.2.1.2 Antigen presentation  
 Although theoretically, any cell subtype expressing MHC molecules could act as an antigen 
presenting cell, only professional APCs, such as DCs, B-cells, and macrophages can successfully 
stimulate T-cells. Professional APCs have certain characteristics that make them effective to initiate 
adaptive immune responses, including the capacity to process antigens and generate antigenic 
determinants, form complexes between MHC molecules and antigens, express co-stimulatory molecules 
and secrete cytokines and adhesion molecules that will stimulate T-cells (Kim et al., 2004).   
To initiate an adaptive immune response, the first step involves the recognition of a peptide-major 
histocompatibility complex class II (pMHC class II) on the surface of an APC by T-cells located mostly 
in secondary lymphoid organs, since they rarely have access to body compartments other than blood, 
lymph nodes, mucosal lymphoid tissues and spleen (Banchereau and Steinman, 1998; von Andrian and 
Mackay, 2000; Reinhardt et al., 2001). The site of entrance of the antigen to the body can determine 
where the T-cell response will begin; antigens entering the skin will be transported to the peripheral 
lymph nodes, while pathogens internalizing through mucosal surfaces or blood, will be presented to T-
cells in mucosal lymphoid organs or spleen, respectively (Jenkins et al., 2001).  
Three main cell lineages expressing MHC class II have been identified in murine lymph nodes: 
macrophages, B-cells and dendritic cells (DCs) (Witmer and Steinman, 1984). However, macrophages are 
unlikely to act as initial APCs, because they usually locate in non-lymphoid tissues and areas where naïve 
T-cells are not present (Witmer-Pack et al., 1993). Moreover, studies in macrophage-deficient mice have 
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shown that these animals can still present T-cell dependent immune responses, which suggests that 
macrophages are not essential for the initiation of T-cell responses (Chang et al., 1995).  
On the other hand, even though B-cells are able to express MHC class II on their surface, they are 
not efficient at taking up antigens and activating T-cells (Lanzavecchia, 1985; Itano et al., 2003). Studies 
in B cell-deficient have also shown that antigen-specific T-cell priming after immunization in vivo is not 
affected by the lack of these cells (Epstein et al., 1995; Topham et al., 1996).  
Since macrophages and B-cells are proven not essential for initial activation of naïve T-cells, it 
can be inferred that DCs are the only subpopulation of cells in the lymph nodes expressing MHC class II 
capable of priming naïve T-cells in vivo (Itano and Jenkins, 2003). This is supported by the evidence of 
studies showing that DCs are capable of efficiently taking up antigens like ovalbumin, ovalbumin-specific 
T-cells can be found around them in 12-24 hrs, indicating that there is a direct interaction between them 
for antigen presentation (Ingulli et al., 1997; Byersdorfer and Chaplin, 2001).  
In the absence of systemic illness or inflammation, DCs patrol the organism through the blood, 
are able to process antigens from a variety of origins and load them onto MHC class I and II molecules, 
for antigen presentation (Banchereau et al., 2000). However, immature DCs are not efficient APCs, and 
they need signals from pathogens and inflammatory molecules (e.g. cytokines) to mature and be able to 
successfully activate naïve T-cells (Banchereau and Steinman, 1998; Banchereau et al., 2000; Bell et al., 
1999). Maturation of DCs not only involves modifications such as increased half-life and expression of 
MHC and costimulatory molecules but also their migration to secondary lymphoid organs, where T-cells 
are located (Gallucci and Matzinger, 2001).  
On the other hand, monocytes usually are not considered an APC, but just a precursor of certain 
populations of macrophages and DCs (Randolph et al., 2008). However, it has been demonstrated that 
monocytes can take up antigens, retain them and present them on MHC II molecules after maturation, 
similarly to DCs (Tacke et al., 2006; Delamarre et al., 2005). If monocytes are able to capture antigens 
while they are in the bone marrow or in the blood, they could possibly act as vehicles, and present a wide 
variety of antigens in different tissues after they differentiate into DCs (Randolph et al., 2008).  
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1.2.2 Adaptive immunity 
The adaptive immune system originated and evolved in order to be able to protect complex 
organisms from mutating pathogens and to be able to recognize an extensive variety of antigenic 
structures (Cooper and Alder, 2006). Contrary to the innate immune system, where all the recognition 
receptors are encoded in the germline genome, the adaptive immunity relies on highly specific receptors 
generated from somatic recombination of a wide variety of gene segments (Murphy and Weaver, 2016). 
These receptors remain for the lifetime of the host and will be able to elicit an expeditious response in re-
infection, due to the immunologic memory (Janeway et al., 2005).  
The primordial cells of the adaptive immune system are T- and B-lymphocytes, which develop in 
the primary lymphoid organs, bone marrow and thymus, .  These cells will migrate to the spleen and 
lymph nodes (secondary lymphoid organs) where they will orchestrate adaptive immune responses 
influenced by innate immunity signals from pathogens or activated APCs (Bonilla and Oettgen, 2010). 
Once activated, B- and T-cells travel through the organism to different tissues guided by different 
chemokines and adhesion molecules (Capra et al., 1999). 
 
1.2.2.1 T-cell immune response 
The process of antigen recognition by T-cells is started by an immunological synapse between the 
T-cell receptors (TCR) and costimulatory molecules expressed on APCs. These events will trigger a 
signaling cascade that could recruit naïve T-cells to the site, depending on the level of stimulation (Dustin 
and Cooper, 2000). The synapse efficiency depends on three main factors: a) the number of complexes 
between MHC and antigen in APCs, b) the level of costimulatory molecules expressed, and c) the 
duration of the signaling process, determined by the stability of the synapse (Lanzavecchia and Sallusto, 
2001).  
 The T-cell response is not homogeneous, and it varies depending on the developmental stage and 
the kind of APC priming the cells. Activated effector and memory T-cells are very efficient in responding 
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to low doses of antigens, and they do not necessarily require co-stimulation. On the other hand, naïve T-
cells are only activated in the presence of costimulatory molecules, or non-physiological high doses of 
antigen. To exemplify this, naïve T-cells could require more than 30 hours of TCR stimulation for 
activation, while effector or memory T-cells could be activated in 0.5 to 2 hours (Lanzavecchia and 
Sallusto, 2001). Activated T-cells produce IL-2 in response to antigenic stimulation, which will enhance 
their proliferation.  
 Although all T-cells share the same mechanisms of activation, they differentiate into a variety of 
effector and intermediate cells, depending on the duration of TCR stimulation and the cytokines produced 
(Lanzavecchia and Sallusto, 2000). Effector cells play different roles in the immune response, killing 
infected cells in order to eliminate pathogens, while helper and regulatory T-cells enhance B- and T-cell 
immune responses and limit the extension of the inflammatory response, respectively (Bonilla and 
Oettgen, 2010).  
 Helper T-cells (TH), members of the	CD4+ αβ TCR population can be divided into TH1 and TH2 
depending on the cytokines they produce after being activated, which are mostly mutually exclusive. 
While TH1 cells produce IFNγ and IL-2 that lead to cell-mediated immunity with the activation of 
phagocytes, NK cells and cytolytic T-cells that destroy infected cells, TH2 cells produce IL-4, IL-5, IL-10 
and IL-13, that enhances the antibody production and regulate immunity against parasites and 
hypersensitivity (Mossman et al., 1986). When TH1 and TH2 are differentiated, they leave the lymph 
nodes and are able to migrate to different tissues to act as effector cells (Lanzavecchia and Sallusto, 
2001).  
 Previously, all T-cell immune responses were thought to be driven by either TH1 or TH2 cells. 
However, newly discovered subsets such as TH9 and TH17 (Steinman, 2007) have been identified. TH9 
cells, resulting from exposure of TH2 cells to IL-4 and TGFβ, produce IL-9, which is involved in anti-
parasitic immunity and acts as a mast-cell growth factor (Veldhoen et al., 2008). In addition, follicular T-
helper cells (TFH) are memory CD4+ cells that drive B-cell activation in germinal follicles (Bonilla and 
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Oettgen, 2010). TH17 cells produce mostly pro-inflammatory cytokines from the IL-17 group (IL-17A-IL-
17F) and are important in the pathogenesis of autoimmunity and asthma (Wang et al., 2008).  
 Another group of cells involved in T-cell immunity are regulatory T-cells (Treg) (part of the	
CD4+ αβ TCR population), which have a critical role in a very complex system that regulates T-cell 
responses (Chatila, 2005).  
 One of the largest groups of circulating T-cells are CD8+, which recognize cells containing 
intracellular pathogens. Cytolytic T-lymphocytes (CTLs) recognize cytosolic antigens through its TCR 
and produce immunologic synapse with the MHC class I molecules of the infected cell, which leads to 
apoptosis in the target cell mediated by CTL granules (Bonilla and Oettgen, 2010).  
 There is a very small subset of T-cells that recognize antigens using non-classical MHC 
molecules. These cells express γδ TCRs, and seem to be particularly important in the response against 
mycobacterial infections (D'Souza et al., 1997).  
Finally, NK cells, another T-cell subset, recognize antigens presented by non-classical MHC 
molecules, similarly to γδ-cells. When activated, these cells produce a high amount of cytokines, which 
links them to various inflammatory processes including allergies and asthma (Meyer et al., 2008).  
 
1.2.2.2 B-cell immune response 
 The adaptive B-cell immune response or humoral immunity is mediated by B-cells that 
differentiate into plasma cells and produce antibodies as a response to antigens with the help of Th2 type 
cells (Bonilla and Oettgen, 2010). For B-cell development, the rearrangement of V, D, and J gene 
segments in the H chain, and V and J genes in the L chain loci of Ig are indispensable (Alt et al., 1986).  
 Antibody production can be initiated in mature B-cells in different ways, depending on the 
involvement of T-cells in the B-cell activation (Bonilla and Oettgen, 2010). T-independent (TI) antigen 
responses are meant to provide a rapid response, even when T-cell recruitment has not been initiated. It 
can be divided into two groups, TI type 1 and type 2. While TI type 1 antigens by themselves can induce 
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cell proliferation and antibody production in mature B cells (Richards et al., 2008), TI type 2 antigens 
need to be recognized by B-cell receptors in conjunction with dendritic cells or cytokine signals (Vos et 
al., 2000). T-cell dependent antibody responses are much more common and involve antigens known as 
“T-dependent.” In this case, B-cells receive a first signal from the antigen, which will activate 
intracellular signaling pathways allowing them to interact with T-cells in secondary lymphoid tissues and 
receive a secondary signal for activation. Like APCs, B-cells can express processed antigens in their 
surface, in a complex between the peptide and MHC class II molecules, and they can interact with the 
mature B-cells, and activate them for further differentiation into memory or plasma cells (Batista and 
Harwood, 2009). The interaction between T- and B-cells is similar to the interaction that occurs between 
T-cells and dendritic cells. Moreover, B-cells can express the same costimulatory molecules as dendritic 
cells, such as CD40, CD80, and CD86 (Hartmann and Krieg, 2000).  
 Activated B cells can follow one of 2 pathways: to become plasma cells and produce low-affinity 
antibodies for a reduced period of time or to establish a germinal center after entering follicles in 
secondary lymphoid tissue (Batista and Harwood, 2009). In the germinal center, B-cells can go through a 
process called “class-switching,” where they can change the production of antibodies from IgM or IgD to 
IgA, IgG or IgE, depending in part to the type of cytokines they are exposed to (Stavnezer et al., 2008; 
Oettgen, 2000). Along with class switching, there is another process occurring at the same time known as 
SHM (somatic hypermutation), where nucleotide substitutions in the sequences of the heavy and light 
chains of immunoglobulins lead to point mutations, causing affinity maturation that will finally result in 
antibodies with higher affinity for the antigen (Steele, 2009; Peled et al., 2008).     
 In the primary immune response, occurring after the first exposure to an antigen, IgM low-affinity 
antibodies are produced initially while the production of isotypes with higher affinity for the antigen, such 
as IgA, IgE and IgG can take 15 days or longer. In this first exposure, memory T- and B-cells are 
generated. If the immune system is challenged with the same pathogen for the second time (secondary 
response), the immune response will be faster, and the production of different high-affinity 
immunoglobulin isotypes is established in the first few days after infection (Bonilla and Oettgen, 2010).  
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Figure 1.4 Schematic representation of cell lineages derived from a common hematopoietic stem cell 
predecessor. Reproduced with permission from Fig. 1 in (Chaplin, 2010).	 Overview of the immune 
response. Place: Elsevier.  
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1.2.3 Peripheral blood mononuclear cells 
Peripheral blood mononuclear cells (PBMCs) are the cellular components of blood that contain a 
round nucleus, such as lymphocytes, monocytes, dendritic cells, and macrophages. Other cellular 
components like erythrocytes and platelets are excluded from this group, since they have no nuclei, and 
granulocytes (eosinophils, basophils, neutrophils) that have a multi-lobed nucleus (Delves et al., 2001).   
 
1.2.3.1 Lymphoid cells 
The common lymphoid progenitor, developed from hematopoietic stem cells, can differentiate 
into a variety of populations of lymphocytes: T-cells, B-cells, NK cells and NK-T cells (Figure 1.4), each 
with a distinctive surface phenotype. B-cells express membrane-anchored immunoglobulins that act as 
receptors for the antigens, although there are several subtypes of these cells, depending on the types of 
antibody they can produce and the antigens to which they react. T-cells can be recognized because they 
express TCR on their surface to interact with APCs, while NK cells lack either TCR or immunoglobulins 
on their surface, but they are distinctively large and granular. Finally, NK-T cells are distinguished from 
NK and T-cells, because they share characteristics of both of those populations (Brignier and Gewirtz, 
2010; Balato et al., 2009).   
 
1.2.3.1.1 B cells 
  In 1948, plasma cells were suggested to be responsible for antibody production, after the first 
identification of serum gammaglobulins (Tiselius and Kabat, 1938) that led to the discovery of B-cells 
(Fagraeus, 1948). B-cells are produced in the bone marrow and go through a series of developmental 
stages that allow them to acquire antigen specificity, even though these cells lack contact with the 
exogenous antigen through their development in a process called “antigen-independent B-cell 
development” (LeBien and Tedder, 2008). Immature B-cells, characterized mostly in mice, are also 
known as transitional cells (T1, T2) acquire cell surface markers CD21 and CD22, as well surface IgD 
when they exit the bone marrow (Chung et al., 2003). These cells can get activated in the presence of T 
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cell-independent antigens, such as lipopolysaccharides (Coutinho and Möller, 1975). However, once B-
cells encounter antigen, they go through an “antigen-dependent phase” of development, get activated and 
become either a memory cell or a plasma cell depending on the stimuli they receive (Desiderio, 1992). A 
combination of cytokines and transcription factors will command the B-cell development; for example in 
mice, IL-7 promotes the rearrangement of V, D and J genes, and sends signals needed for proliferation 
and survival of B-cells (Milne and Paige, 2006). At least 10 transcription factors are involved in B-cell 
development, although Pax5, E3A, and EBF are the best known for being involved in B-lineage 
commitment and B-cell differentiation (Nutt and Kee, 2007). 
 After maturation, B-cells reside mostly in gut-associated lymphoid tissue (GALT) or in lymphoid 
follicles in lymph nodes and spleen, where they can encounter T cell-dependent antigens, proliferate and 
differentiate into plasma cells or start GC reactions. B-cells are activated and differentiate in secondary 
lymphoid tissues in a series of events named germinal center (GC) reaction, where class switch 
recombination (CSR), somatic hypermutation (SHM) and affinity maturation of BCR for specific antigens 
occur (LeBien and Tedder, 2008).  
Long lasting antigen-specific antibody responses require long-lived plasma cells. Plasma cells are 
generated in the spleen and eventually migrate to the bone marrow, where they can live for as long as the 
lifetime of the individual. They can be produced by primary and secondary immune responses (Radbruch 
et al., 2006). There are plasma cell pools in the spleen and bone marrow. When depleted, they are 
replenished from the pool of memory B-cells, that can be differentiated into long-lived plasma cells and 
produce antibodies if they sense certain cytokines or Toll-like receptor signals (DiLillo et al., 2008). 
Even though B-cells are known for their role in humoral immunity, they also have other functions related 
to immune homeostasis. B-cells can initiate T-cell immune responses by processing and presenting 
antigens to T-cells through MHC, although this activation can produce different immune responses than 
the one started by DCs (LeBien and Tedder, 2008). Furthermore, B-cells can produce cytokines that will 
influence T-cell differentiation (Harris et al., 2000). B-cells can also secrete immunomodulatory 
cytokines that regulate a variety of functions like tumor development and immunity, tissue rejection, and 
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wound healing among others (LeBien and Tedder, 2008). In addition, there is a specific subset of 
regulatory B-cells that produce IL-10 and regulate inflammatory responses mediated by T-cells (Yanaba 
et al., 2008).  
 
1.2.3.1.2 T cells 
T-cells are able to recognize antigens when their TCR interacts with the MHC-antigen complex displayed 
by APCs (Germain, 1994; Davis et al., 1998). This interaction initiates T-cell proliferation and further 
differentiation into a variety of cells that can determine the type of immune response that will follow. 
CD4+ T-cells can differentiate into TH1 or TH2 that can protect against intracellular or extracellular 
microorganisms and will produce different cytokines: IFNγ or IL-4, IL-5, and IL-13, respectively (Abbas 
et al., 1996; Romagnani, 1994). When CD8+ T-cells differentiate into cytotoxic T-cells, they gain the 
capability of detecting and destroying virus-infected cells (Zinkernagel, 1996). There are also some 
subsets of regulatory T-cells, such as TH cells that visit B-cell areas to trigger T cell-dependent antibody 
responses or T-cells that can down-regulate immune responses producing inhibitory cytokines (Faria and 
Weiner, 1999).  
The primary response against an antigen can generate T-cells that can survive as memory cells 
(for years), which can get activated and, provide fast and effective immune responses in case of re-
infection with the same pathogen (Ahmed and Gray, 1997; Dutton et al., 1998).  
 In bovine, γδ T-cells are one of the most important subsets of circulating lymphocytes (15-60%) 
(Davis et al., 1996). These cells can be activated without the presence of MHC-peptide complexes, and 
perform varied functions, such as antigen presentation, cytokine production and immune regulation (Pang 
et al., 2012; Kabelitz et al., 2013). γδ T-cells seem to have a role in immune suppression in ruminants 
(Rhodes et al., 2001; Brown et al., 1994). Bovine γδ T-cells have an important regulatory role, secreting 
IL-10 spontaneously that will inhibit proliferation of CD4 and CD8 T-cells in vitro, in cells activated in 
either antigen-specific or non-specific pathways (Guzman et al., 2014). In contrast, regulatory T-cells 
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(Tregs) are vital for the immune system balance, and they usually express CD4, CD25, and Foxp3 (Hori 
et al., 2003). However, CD4+CD25high Foxp3+ T-cells in the bovine do not seem to have a regulatory 
function in vitro (Hoek et al., 2009).   
 
1.2.3.1.3 NK cells 
 Natural killer (NK) cells were first identified because of their large size, granularity, and due to 
their ability to provoke lysis in tumor cell lines (Trinchieri, 1989). Natural killer cells are known for 
protecting the organism against a great variety of pathogens and cancers. Their role in the innate immune 
responses is to fight primarily against viruses, in an NK cell-mediated toxicity induced by type I IFN 
(Biron et al., 2002).  
 NK-cells can be divided into two groups: classical NK-cells and NKT-cells. Classical NK-cells 
do not express TCR, are developed in the bone marrow and, are mostly present in the bloodstream and 
spleen (Biron et al., 1999). On the other hand, NKT-cells are found within T-cell populations, in small 
numbers in the thymus and spleen, but in a significant number in the liver. NKT-cells express TCR 
although they have a restricted repertoire (Eberl et al., 1999).  
Classical NKs play an important role in anti-viral immunity, not just through NK cell-mediated 
cytotoxicity but also by producing IL-12 that will stimulate IFNγ production, which is known for having 
direct anti-viral functions and an activator of pathways that will promote protective immune responses 
(Biron et al., 2002). NK-cells can also produce TNF and trigger chemokine secretions that promote 
inflammatory processes and attract other cell populations (Bluman et al., 1996). 
 
1.2.3.2 Myeloid cells 
Myeloid stem cells or common myeloid progenitors are the precursor cells of erythrocytes, 
platelets, megakaryocytes, and the cells of the granulocyte lineage, such as neutrophils, eosinophils, 
basophils, monocytes, macrophages and mast cells (Figure 1.4). These cells are very important in the 
innate immune system because they can trigger the adaptive immune system acting as APCs. They have 
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phenotypic and functional differences based on their location and the variety of tissues they have been 
seen previously (Serbina et al., 2008).  
 
1.2.3.2.1 Monocytes 
 Monocytes are not just precursors for dendritic cells and macrophages, but they also have an 
active role in the innate immune system, especially in infection and inflammation (Lavau et al., 2014). 
They have been characterized based on their phagocytic, pathogen-sensing, ability to produce 
cytokines/chemokines and ability to present antigens to T-cells (Geissmann et al., 2010).  
Monocytes in humans and mice are divided into three subpopulations depending on their 
expression of CD14 and CD16 that share similar phenotypical and functional characteristics between the 
two species (Ziegler-Heitbrock, 2007). The largest monocyte subpopulation is usually designated as 
“classical” (cM), and the smallest group is referred to as “non-classical” (ncM), while the level of markers 
in the intermediate population (intM) is not well defined (Ziegler-Heitbrock, 1996).  
Studies in mice have shown that the classical monocyte subpopulations have an active role in 
inflammation and in containing infections as they can be found at the site of infection attracted by 
cytokine and chemokine signals, to later be differentiated into dendritic cells and macrophages (Wong et 
al., 2011). In humans, classical monocytes respond in a similar way to TLR ligands, leading to 
upregulation of pro-inflammatory cytokines and IL-10, although intermediate monocytes could be 
responsible for IL-10 production (Wong et al., 2012). Alternatively, non-classical monocytes are mostly 
located in the blood vessels, patrolling the endothelium, and express mostly tumor necrosis factor alpha 
(TNFα) (Frankenberger et al., 1996; Belge et al., 2002).  
 In bovine, monocytes express CD172a (signal-regulatory protein alpha) among all 
subpopulations, although they are commonly subdivided into three subpopulations depending on the 
expression of CD14 and CD16, similarly to humans: cM are CD14++ CD16-, intM are CD14++ CD16+, and 
ncM are CD14- CD16++, being cM the most abundant of bovine monocytes (89%) (Hussen et al., 2013).  
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The functions of bovine monocytes also appear to be similar to the ones found in humans; bovine 
cM, like their human counterparts, have the highest capacity for bacteria phagocytosis (Zawada et al., 
2011; Cros et al., 2010). Bovine intM produce high levels of reactive oxygen species (ROS) and 
inflammatory cytokines, such as IL-1β and TNFα, while ncM evidence a very low ability to produce ROS 
and pro-inflammatory cytokines and to phagocyte (Hussen et al., 2013).  
 Although human and murine ncM are known for their ability for neutrophil recruitment to 
inflamed tissues, this characteristic has not been found in bovine ncM (Auffray et al., 2007; Hussen et al., 
2013).  
Bovine intM seem to have clinical significance in inflammatory processes, especially in the acute phase, 
when they are recruited in large numbers in the draining lymph nodes and elicit a high gene expression of 
a large variety of inflammatory mediators and cytokines (Düvel et al., 2014; Lund et al., 2016).  
 
1.2.3.2.2 Macrophages 
 Macrophages are derived from monocytes localized in the bloodstream and bone marrow. These 
mononuclear phagocytes acquire certain abilities when they relocate to different tissues. While Kupffer 
cells in the liver have a phagocytic function to remove foreign toxins and materials in that organ, alveolar 
macrophages in the lung can produce and secrete cytotoxic oxidants to fight air-borne pathogens (Laskin 
et al., 2011).  
 Macrophages are considered cellular components of the innate immune response because they 
eliminate a diverse variety of pathogens, tumor cells, apoptotic cells, and debris. In addition, they can 
trigger inflammatory responses when they encounter danger signals in case of infection or injury (Zhang 
and Mosser, 2008). Moreover, these cells can act like professional APCs and induce activation of T-cells 
that will initiate a specific adaptive immune response (Mosser and Edwards, 2011).  
 There are two well-characterized major subpopulations of macrophages: M1, or classically 
activated macrophages, and M2 or alternatively activated macrophages. M1 macrophages are activated by 
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PAMPs, type I cytokines (such as TNFα and IFNγ) and endogenous danger signals, eliciting very strong 
activity against microbes and tumors by releasing IL-12 and IL-23 that promote Th1 immune responses 
(Laskin, 2009). On the other hand, M2 macrophages are responsible for downregulating inflammation 
through the production of anti-inflammatory cytokines (IL-4, IL-10, IL-13) and mediators involved in 
tissue repair (Martinez et al., 2008).  
 
1.2.3.2.3 Dendritic cells  
 Dendritic cells are the most efficient APCs and the only APC capable of priming naïve T-cells 
(Palucka and Banchereau, 1999; Sh ortman and Liu, 2002). Although mature DCs play a main role in 
antigen presentation and activation of T-cells, recent studies suggest that they also play a role in induction 
of immunological tolerance (Akbari et al., 2001; Joffre et al., 2009). To process the antigens, DCs can 
internalize them through phagocytosis, receptor-mediated interactions and micropinocytosis (Inaba et al., 
1993; Moll et al., 1993; Sallusto et al., 1995). They also play a role in interactions between T- and B-cells 
leading to antibody production, due to their ability to produce large amounts of IL-12 (Cella et al., 1996; 
Koch et al., 1996; e Sousa et al., 1999).  
 DC maturation occurs while they migrate through the blood or lymph, to the spleen or lymph 
nodes, respectively, which involves changes in MHC class II expression, costimulatory molecules and 
their capacity to process antigens (De Smedt et al., 1996; Kudo et al., 1997; Inaba et al., 1994; Schuler 
and Steinman, 1985). The stage of development of DCs play a role in their ability act as APCs. Although 
immature DCs are very efficient in processing the antigen, they lack the ability to activate naïve T-cells, 
whereas mature DCs cannot take up proteins efficiently, but have a high capacity of antigen presentation 
(Winzler et al., 1997; Cella et al., 1997). 
 There are many subpopulations of DCs which possess unique functional and phenotypical 
characteristics, different tissue distributions and trigger different T-cell responses (Steinman and Cohn, 
1973; Fries et al., 2011; de Jong et al., 2005). The four major subsets of DCs are conventional DCs, 
Langerhans cells, monocyte-derived DCs (MoDCs) and plasmacytoid DCs (pDCs). Conventional DCs are 
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specialized in antigen presentation and they can circulate (migratory DCs) or reside in tissues. Langerhans 
cells are located in the skin and migrate to the lymph nodes when they find an antigen to present to T-
cells. MoDCs are professional APCs and can be rapidly recruited to the site of inflammation or when a 
danger signal is present (Belz and Nutt, 2012). In contrast, pDCs have very poor antigen-presentation 
abilities, and their role in the immune response is unclear (Reizis et al., 2011).  
 Since the DC population in blood is very low (less than 1% of PBMCs), different techniques have 
been developed in order to acquire a higher number of cells. The most common methods involve the 
stimulation of CD14+ monocytes and bone marrow precursors with IL-4 and granulocyte-macrophage 
colony-stimulating factor (GM-CSF), to generate MoDCs and BMDCs (Pinchuk et al., 2003). However, 
the T-cell and humoral immune responses induced by BMDCs and MoDCs are different than the ones 
elicited by blood DCs in humans and bovine (Osugi et al., 2002; Pinchuk et al., 2003).  
 In bovine, the lineage markers in DC are not compatible with B-cells (CD21), monocytes 
(CD14), T-cells (CD3) or NK cells (CD335) (Renjifo et al., 1997). Bovine DCs express adhesion 
molecules and CD205 at high or low levels which have helped to identify two defined myeloid DC 
(mDCs) populations: CD205Hi and CD205Lo. Although both are very efficient in processing antigens, they 
have different abilities to activate T-cells. When compared to CD205Hi, CD205Lo has a higher capacity to 
upregulate costimulatory molecules CD40, CD80 and CD86, and TGFβ in T cells (González-Cano et al., 
2014).  
 
1.3 Adenovirus as a vaccine delivery vehicle 
Recombinant adenoviruses were first used as a delivery vehicle for gene therapy (Wilson, 1996), 
until their potential as vaccine vectors to carry pathogen or tumor genes was discovered (Tatsis and Ertl, 
2004; Lasaro and Ertl, 2004). One of their advantages is that they are able to trigger strong and long-
lasting immune responses against specific antigens after administration via systemic and mucosal routes 
(Fitzgerald et al., 2003; Xiang et al., 2003). Furthermore, adenovirus-based vectors can accommodate 
large segments of foreign DNA in their genomes, they can be grown to high titers in cell lines under 
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laboratory conditions, and there are well-established protocols for their production and purification, which 
makes them a convenient option for clinical use (Tatsis et al., 2006).  
The most widely studied adenovirus as a vaccine vector is human adenovirus serotype 5 (HAdV-
5), which causes mild respiratory symptoms in naturally-infected patients. Replication-competent and 
defective recombinant HAdV-5 vectors have been developed and used to deliver vaccine antigens in 
dogs, mice, and even non-human primates (Xiang et al., 1996; Fischer et al., 2002; Shiver et al., 2002). 
In humans, adenoviral vectors have been studied as vaccine candidates against hepatitis C, 
influenza A, HIV, tuberculosis, malaria, SARS, and Ebola, with the vaccines specific forHIV and malaria 
the most widely tested (Appaiahgari and Vrati, 2015). Some adenovirus-based vaccines have been 
evaluated in animals against diseases such as rabies and foot and mouth disease (Li et al., 2006a).  
Although pre-clinical and clinical testing of adenoviral vectors for vaccine delivery have been 
promising, there are concerns about the safety of these vectors, especially after a patient that received 
adenovirus-based gene therapy died due to a systemic inflammatory response attributed to the virus 
(Raper et al., 2003). Adenovirus vectors come in contact with several blood factors after administration, 
including platelets, which can produce adenovirus-induced thrombocytopenia (Othman et al., 2007).  
When adenovirus vectors are inoculated systemically (intravenous route), there is an activation of 
the innate immune response that occurs between 30 minutes to 6 hours post-inoculation, after the 
interaction between the virus and TLRs (Toll-like receptors) (Appledorn et al., 2008; Rhee et al., 2011), 
blood clotting factors (Shayakhmetov et al., 2005; Greig et al., 2009), and mediators of common, 
classical, and alternative complement factors (Tian et al., 2009).  Later on, in a process that can occur 
from hours to a few days after inoculation, adenovirus-associated molecular patterns are recognized by 
TLR2 and TLR9, which activate pathways responsible for the induction of inflammatory cytokines and 
chemokines such as IL-6, IL-8, IL-12, TNFα, and interferons γ and λ, among others (Appledorn et al., 
2008; Cerullo et al., 2007). In this process, thrombocytopenia and liver damage can occur (Seiler et al., 
2007). Finally, adaptive immune responses against the adenovirus vector can develop in response to viral 
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gene expression and subsequent antigen presentation, which results in the generation of adenovirus-
specific CD8+ T-cells and humoral immune response (Segura, 2008). 
Pre-existing antibodies against HAdV-5 have been found in 30-100% of the human population, 
depending on the geographical location (Mast et al., 2010; Barouch et al., 2011), which results in early 
clearance of the cells transduced with the vector (Buchbinder et al., 2008; Gray et al., 2010). Moreover, 
in individuals previously exposed to the virus, the adaptive immune response after administration is 
strong, and the inflammatory responses can be fatal (Zaiss et al., 2009). Another challenge is that more 
than 85% of the vector accumulates in the liver shortly after administration, where Kupffer cells and 
LSECs (liver sinusoidal endothelial cells) limit the transduction of target cells, although some virus can 
enter the liver parenchyma and transduce hepatocytes, which results in high-level expression of transgene 
(Khare et al., 2011).  
Recent in vivo studies in mice have shown that specific antibody titers against adenovirus vectors 
decrease between 6 and 10 months post-inoculation, while specific humoral and cell-mediated immunity 
against the vaccine antigen increases (Mittal et al., 2018). These results suggest that, even with pre-
existing immunity against the vector, repeated vaccination using the same vector can be performed if 
there is a window period between inoculations. 
 
1.3.1 Altered tropism 
 A number of characteristics have led to the development and evaluation of adenovirus vectors for 
vaccination and gene therapy (Kotterman et al., 2015). These include wide tropism, easy construction of 
recombinant adenovirus, relatively large insertion capacity for foreign genes and high virus titers can be 
produced in laboratory conditions (Nicklin and Baker, 2002). However, the efficiency of adenovirus 
vectors is decreased if the target cells lack expression of the primary receptors for adenoviral attachment, 
or because the primary receptor is expressed in a great variety of cells in the host (Mizuguchi and 
Hayakawa, 2004). 
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 To overcome these limitations, researchers have developed and used several approaches for 
developing adenovirus vectors with altered tropism (Table 1.2). 
 
1.4 BAdV-3 as a vaccine vector 
BAdV-3 has been studied as a vaccine delivery vehicle in cattle because it has a restricted host 
range, is non-pathogenic, can be grown to high titers in laboratory and can be delivered intranasally, 
which is advantageous in food-producing animals immunization by this route does not affect meat quality 
(Ayalew et al., 2015).  
Biodistribution studies in mice have demonstrated that BAdV-3 vectors efficiently transduce 
mostly liver and spleen cells, but also heart, kidney, and lung cells, and have a longer persistence in those 
organs than HAdV-5 or PAdV-3 vectors (Mittal et al., 2009).  
Initial efforts focused on developing recombinant replication-competent BAdV-3 vaccine vectors 
containing the deletion of E3 region (a non-essential region for viral replication) for insertion of foreign 
genes (Zakhartchouk et al., 1998; Reddy et al., 2000; Baxi et al., 2000). Vaccine antigens from both 
DNA and RNA viruses were successfully expressed by replication-competent BAdV-3 (Zakhartchouk et 
al., 1998; Baxi et al., 2000; Reddy et al., 2000b; Brownlie et al., 2015). Vaccines using recombinant 
replication competent BAdV-3 expressing antigenic proteins of BHV-1 and BVDV, administered 
intranasally to cotton rats have shown antigen-specific immune responses after two doses (Zakhartchouk 
et al., 1998; Baxi et al., 2000). However, there was a concern about the use of BAdV-3 as a vector in 
cattle because of the level of pre-existing antibodies in the field (Ghirotti et al., 1991; Lehmukhul et al., 
1979; Roshtkhari et al., 2012). Because of this issue, calves with significant levels of pre-existing 
neutralizing antibodies against BAdV-3 were immunized with the recombinant vector expressing a BHV-
1 protein intranasally in two doses, and challenged with BHV-1 two weeks later. Immunization of calves 
induced BHV-1 specific humoral immune responses and absence of development of clinical disease, 
which shows that intranasal immunization with BAdV-3 in calves can overcome the effect of BAdV-3 
specific pre-existing neutralizing antibodies in calves (Zakhartchouk et al., 1999). Interestingly, calves  
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Approach Modification Examples 
Modification 
of capsid 
proteins 
Fiber Addition of peptides in C-terminus or HI loop (Wickham et al., 
1997; Dmitriev et al., 1998; Mizuguchi et al., 2001; Koizumi et al., 
2003b; Sharma et al., 2017) 
Substitution with fibers from different Adenoviruses (Stevenson et 
al., 1997; Shayakhmetov et al., 2000; Mizguchi and Hayakawa, 
2002; Chondronasiou et al., 2018).  
Removal of knob domain from fiber protein (Hong et al., 2003; 
Gaden et al., 2004).  
pIX Insertion of ligands at C-terminus of pIX (Dmitriev et al., 2002; Le 
et al., 2004; Vellinga et al., 2004; Salisch et al., 2017). 
Penton base Deletion of RGD motif to prevent binding to αv integrins (Mizguchi 
et al., 2002; Einfeld et al., 2001; Koizumi et al., 2003a).  
Use of adaptor 
molecules 
Anti-fiber 
monoclonal 
antibody 
(mAb) 
Anti-fiber mAb conjugated with different ligands (folate, fibroblast 
growth factor 2, epidermal growth factor receptor, anti-CD40) and 
complexed with adenovirus vector (Douglas et al., 1999; Sosnowski 
et al., 1999; Miller et al., 1998; Tillman et al., 1999). 
Modified 
capsid proteins 
Combination of genetically-modified capsids and adaptor molecules 
(Henning et al., 2002; Volpers et al., 2003) 
Metabollically biotinylated adenovirus vectors (Parrott et al., 2003; 
Campos et al., 2004) 
Chemical 
modification 
Polyethylene 
glycol 
Modified adenovirus with PEG interacting with lysine residues in 
capsid proteins (Alemany et al., 2000; Croyle et al., 2002; Ogawara 
et al., 2004). 
Addition of functional molecules on the tip of PEG in adenovirus 
vectors (Lanciotti et al., 2003; Ogawara et al., 2004; Eto et al., 
2005; Kasala and Yun, 2016). 
Others Use of multivalent hydrophilip polymers (Fisher et al., 2001; Green 
et al., 2004) 
 
Table 1.2. Approaches for elaboration of adenovirus vectors with altered tropism. 
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immunized with replication-defective BAdV-3 expressing BHV-1 vaccine antigen subcutaneously did not 
show induction of protective immune response, and protection against BHV-1 challenge (Reddy et al., 
2000).  
Subsequently, replication-defective BAdV-3 vectors containing deletion of E1A and E3 region 
were developed (Reddy et al., 1999). However, immunization of calves with replication defective 
recombinant BAdV-3 expressing BHV-1 vaccine antigen did not show either an induction of an immune 
response or protection against BHV-1 challenge (Reddy et al., 2000b). 
Studies in mice comparing BAdV-3and HAdV expressing HA of influenza virus demonstrated 
that the BAdV-3 based vector stimulated more potent cellular immune responses than HAdV and offered 
complete protection against challenge when delivered using intramuscular route. Moreover, intranasal 
inoculation with BAdV-3-HA vector enhanced cellular and humoral immune responses in mice and 
provided complete protection in mice, even at doses 30-fold lower than intramuscular (Mittal et al., 
2018). 
 
1.4.1 Altering tropism of Bovine Adenovirus-3 
Although BAdV-3 has been demonstrated to be a suitable vaccine vector for the delivery of 
antigens to respiratory mucosal surfaces in cattle, two vaccinations are required to induce protective 
immunity (Zakhartchouk et al., 1999). Targeting BAdV-3 to different cells could improve the vector 
efficiency, and allow vaccine administration by different routes, even orally (Ayalew et al., 2015), which 
could prove more economical.  
Efforts have been made to change the tropism of BAdV-3 through genetic manipulation of capsid 
proteins fiber and pIX. BAdV-3 expressing chimeric fiber (knob region of BAdV-3 fiber replaced with 
knob region of HAdV-5 fiber) significantly increased the transduction efficiency of recombinant BAdV-3 
(Wu and Tikoo, 2004)  in non-bovine cells. The recombinant virus transduction efficiency was between 
3-67 fold higher than wild-type BAdV-3 with an unmodified fiber. In addition, early and late viral 
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proteins could be detected in transduced human cells, which suggests that BAdV-3 tropism can be 
modified for non-bovine cells transduction (Wu and Tikoo, 2004). On the other hand, pIX can be 
modified inserting large polypeptides in its C-terminus region, and it has been shown that the insertion of 
targeting ligands in this protein can enhance the tropism in a fiber-independent manner (Zakhartchouk et 
al., 2004). Targeting BAdV-3 to different cells could improve the vector efficiency, and allow vaccine 
administration in different routes, even orally (Ayalew et al., 2015).  
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2. HYPOTHESIS AND OBJECTIVES 
Like other adenoviruses, BAdV-3 has been developed and evaluated as a vaccine delivery vehicle 
in cattle (Ayalew et al., 2015). However, development of protective immune responses using recombinant 
BAdV-3 based vaccines require two immunizations (Kumar et al., 2014; Zakhartchouk et al., 1999). One 
way to develop a single shot BAdV-3 vectored vaccine is to target BAdV-3 to antigen presenting cells. 
Since the C-terminus of BAdV-3 minor capsid protein pIX is exposed to the exterior of the virion capsid, 
efforts have been made to use it to add targeting ligands, so that recombinant BAdV-3 expressing 
chimeric pIX can be targeted to a particular cell (Zakhartchouk et al., 2004).  
We hypothesize that a recombinant BAdV-3 expressing an RGD motif fused to the C-terminus of 
the pIX protein can enhance the transduction efficiency of bovine peripheral bovine mononuclear cells 
(PBMCs), especially the population of antigen presenting cells (APCs), compared to the wild-type 
BAdV-3 virus. 
The objectives of this work are:  
a) Construct and characterize a recombinant BAdV-3 expressing GFP and a chimeric pIX (RGD fused to 
C-terminus of pIX). 
2) Determine the transduction efficiency of recombinant BAdV-3 expressing RGD in different 
populations of peripheral blood mononuclear cells (PBMCs).  
3) Evaluate the expression of activation markers and cytokine expression in bovine monocytes after 
transduction with recombinant BAdV-3 expressing RGD. 
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3. TRANSDUCTION OF BOVINE PERIPHERAL BLOOD MONONUCLEAR CELLS WITH 
RECOMBINANT BOVINE ADENOVIRUS-3 EXPRESSING CHIMERIC PIX  
 
3.1 INTRODUCTION  
 
Due to the natural ability of viruses to enter cells and efficiently deliver genetic material, different 
viruses have been evaluated for delivery of foreign DNA into cells (Liu, 2010). Through the use of 
molecular virology, the development of highly attenuated recombinant viruses has led to production of 
efficient and safe vaccine vectors for vaccination of animals and humans (Rollier et al., 2011). A number 
of viruses including pox virus (Townsend et al., 2017), herpesvirus (Palya et al., 2014), adeno-associated 
virus (Büning and Schmidt, 2015) retrovirus (Wang et al., 2015) and adenovirus (Tatsis and Ertl, 2004) 
have been developed and evaluated as vaccine delivery vectors.  
Adenoviruses have been studied as vaccine vectors because they constitute an efficient method of 
gene delivery in a variety of human and animal cells (Maheshri et al., 2006). They are not only able to 
trigger strong and long-lasting immune responses against specific antigens when administered through 
different routes (Fitzgerald et al., 2003; Xiang et al., 2003), but are also easily grown and purified in 
laboratory conditions (Kamen and Henry, 2004). Moreover, the adenovirus genome can integrate large 
inserts of foreign DNA (Tatsis et al., 2006).  
Bovine adenovirus-3 (BAdV-3) is being developed and evaluated as a vaccine delivery vehicle 
for cattle (Ayalew et al., 2015). It is a non-enveloped DNA virus with an icosahedral capsid. The genome 
of BAdV-3 is 34,446bp and is organized into early, intermediate, and late regions (Reddy et al., 1998). 
BAdV-3 has been studied as a vaccine vector candidate because is non-pathogenic, has restricted host-
range, grows to high titers and can be delivered intranasally (Ayalew et al., 2015; Zakhartchouk et al., 
2004). However, in -vivo studies using recombinant BAdV-3 expressing bovine herpesvirus-1 gDt show 
that induction of protective immunity against BHV-1 challenge in calves requires two immunizations 
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three weeks apart (Kumar et al., 2014; Zakhartchouk et al., 1999). Since economy plays an important role 
in developing and marketing veterinary vaccines, the prospect of developing single shot vaccines may 
help in increasing economic benefits. 
In order to achieve a more efficient immune response, and a more cost-effective vaccine vector 
candidate, one of the approaches is to improve the transduction efficiency of the BAdV-3 in antigen 
presenting cells (APCs) that would initiate strong adaptive immune responses. Since BAdV-3 utilizes 
primarily sialic acid receptors to enter the cells, this may hinder the efficient transduction of BAdV-3 
based vectors in integrin-positive cells, such as leukocytes, including APCs (Li et al., 2009; Khosa, 
2016).  
To overcome this, selected viral capsid protein(s) could be modified so that recombinant 
adenovirus can enter non-permissive cells (Belousova et al., 2002; Dmitriev et al., 2002). Earlier studies 
demonstrated that modification of major capsid protein fiber (Wu and Tikoo, 2004) or minor capsid 
protein pIX (Zakhartchouk et al., 2004) alters the tropism of BAdV-3. Here, we describe the construction 
and evaluation of a recombinant BAdV-3 that incorporates an RGD motif in the C-terminus of the minor 
capsid protein pIX of the virus. The results indicate that recombinant BAdV-3 expressing chimeric pIX 
(c-terminus of pIX fused to RGD) increases the viral transduction of PBMCs, especially monocytes. 
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3.2 MATERIALS AND METHODS 
 
3.2.1 Cells and viruses 
Madin Darby Bovine Kidney (MDBK) (Madin and Darby, 1958; ATCC CCL-22 ) and VIDO 
DT1 (Du and Tikoo, 2010) cells were grown in minimum essential medium (MEM; Sigma-Aldrich, St. 
Louis, MO, USA) enriched with 2% sterile filtered fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, 
MO, USA), 0.1 mM non-essential amino acids (NEAA, Thermo Fisher Scientific, Waltham, MA, USA), 
10 mM HEPES (Thermo Fisher Scientific, Waltham, MA, USA) and 50 µg/ml gentamicin (Thermo 
Fisher Scientific, Waltham, MA, USA). Recombinant BAV304a (BAdV-3 expressing GFP inserted in E3 
deleted region) (Du and Tikoo, 2010), recombinant BAV951 (BAdV-3 with C-terminus region of pIX 
fused to EYFP) (Zakhartchouk et al., 2004), and recombinant BAV888 (BAV304a expressing chimeric 
pIX [C-terminus of pIX fused to a 10GS spacer, cathepsin cleavage site and RGD motif]) were 
propagated, purified by CsCl and titrated as previously described (Kulshreshtha et al., 2004).   
 
3.2.2  Antibodies 
Production and characterization of anti-BAdV-3 pIX sera has been described (Zakhartchouk et 
al., 2004). Antibodies used to perform flow cytometry experiments are listed in tables 3.1 and 3.2.  
 
3.2.3  Plasmid construction 
To isolate recombinant BAdV-3, full length BAdV-3 plasmid containing chimeric pIX was 
constructed following standard DNA manipulation techniques, as described earlier (Zakhartchouk et al., 
2004).  
a) Plasmid pBAVNdA-10GS-CATRGD. Plasmid pBAVNdA plasmid (Zakhartchouk et al., 2004) 
(containing E1A and E1B regions and protein pIX DNA sequence of the BAdV-3 genome followed by a 
10GS linker sequence) was digested with HpaI -XhoI (nt 4181) restriction enzymes. Oligonucleotides 
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containing a cathepsin cleavage site (de Vrij et al., 2012) and Arg-Gly-Asp (RGD) sequence were 
annealed creating overhangs for HpaI and XhoI sites and ligated to the HpaI-XhoI digested plasmid 
pBAVNdA DNA creating plasmid pBAVNdA-10GS-CATRGD. 
b) Plasmid pUC304a-CATRGD. Homologous recombination in E. coli BJ5183 (Chartier et al., 
1996) was performed between the digested plasmid pUC304a DNA (containing the genome of BAdV-3 
with a GFP cassette in the E3 deleted region; Du & Tikoo, 2010), and an Ase1-Not1 11kb DNA fragment 
of plasmid pBAVNdA-10GS-CATRGD, creating plasmid pUC304a-CATRGD. 
 
3.2.4 Isolation of recombinant BAdV-3 
VIDO DT1 (Du and Tikoo, 2010) cells in a 6-well plate (1x106 cells/well) were transfected with 
4-6µg/well of plasmid pUC304a-CATRGD DNA using Lipofectamine 2000 (Invitrogen, CA, USA). At 6 
hrs post-transfection, the medium was replaced with fresh MEM containing 2% FBS (MEM; Sigma-
Aldrich, St. Louis, MO, USA; FBS; Sigma-Aldrich, St. Louis, MO, USA) and the cells were observed 
daily under the microscope for any signs of cytopathic effect (CPE). After 15 to 20 days post transfection, 
the cells showing CPE were collected, freeze-thawed three times and used for viral purification (Tollefson 
et al., 2007). 
 
3.2.5 Virus growth 
MDBK cells were grown in MEM with 10% FBS (MEM; Sigma-Aldrich, St. Louis, MO, USA; 
FBS; Sigma-Aldrich, St. Louis, MO, USA) in T150 flasks (Corning Inc., NY, USA) until they reached a 
confluency of ~70-80%. Before infection, the media was removed from the flask and cells were washed 
once with MEM without FBS. Next, the cells were infected with individual virus at MOI 1. The infected 
flasks were incubated at 37°C on a rocking platform for 90 min. After incubation, the medium in the 
flasks was discarded and replaced with MEM with 2% FBS. Cells were examined daily, and were 
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collected between 36 and 48 hrs post-infection, when at least 80% of the cells were showing signs of 
cytopathic effect (CPE) or fluorescence, and stored at -80°C in 5ml of medium. 
 
3.2.6. CsCl gradient centrifugation 
MDBK cells infected with each individual virus were harvested at 48 hrs post infection. After 
five rounds of freezing and thawing, 1.5% Nadeoxycholate was added to the lysate and the mixture was 
incubated at room temperature for 30 min. The cell lysate was then combined with 150 µl 2 M MgCl2 and 
75 µl DNase I solution and incubated for additional 30 min at 37°C before centrifuging for 15 min at 
5000 rpm. The supernatant was collected and subjected to CsCl density gradient centrifugation at 
35000rpm at 10°C for 1 hour. Two bands were observed after centrifugation. The lower band 
corresponding to mature virus was collected and subjected to a second round of CsCl gradient 
centrifugation at 4°C for 20 hrs. The band containing the virus was collected and dialyzed using dialysis 
cassettes (Thermo Fisher Scientific, Waltham, MA, USA) submerged in 0.1M Tris-HCl overnight to 
remove any traces of CsCl. Afterward repeating the process three times, the content of each cassette was 
recovered, pooled. The titer of the virus was determined as described earkier (Kulshrestha et al., 2004). 
Finally, the virus was stored at -80 °C, in 100 µl aliquots. 
	
3.2.7 Western Blotting 
The proteins were analyzed by Western blot as described earlier (Kulshrestha et al., 2004). 
Briefly, MDBK cells grown in 6-well plates were mock-infected or infected with individual virus at a 
MOI of 1. After 48 hrs, the cells were collected, lysed with RIPA buffer (Sigma-Aldrich, St. Louis, MO, 
USA) and proteins were separated by 15% SDS-PAGE gel. Finally, the proteins were transferred to 
nitrocellulose membrane (Bio-Rad, CA, USA) and probed using protein specific antisera produced in 
rabbit followed by alkaline phosphatase-conjugated goat anti-rabbit IgG as secondary antibody 
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(Invitrogen, CA, USA). The target protein bands were visualized using BCIP solution (Sigma-Aldrich, St. 
Louis, MO, USA). 
 
3.2.8 Purification of bovine blood cells 
All animal experimental procedures were evaluated and approved by University of Saskatchewan 
– University Committee on Animal Care and Supply (Phlebotomy Protocol #20180015). All procedures 
were executed following guidelines approved and permitted by the Canadian Council on Animal Care.  
 
3.2.9 Peripheral blood mononuclear cells (PBMCs)  
The PBMCs were purified as described previously (Arsenault et al., 2009). Briefly, venous blood 
from male calves (9 and 12 months old) was collected in syringes containing 7.5% EDTA (Sigma-
Aldrich, St. Louis, MO, USA) and centrifuged at 1400 x g at room temperature for 20 min. The buffy 
coat layer was collected, mixed with PBSA + 0.1% EDTA to complete 20 ml before cautiously layering 
over a 60% Percoll (GE Healthcare, Chicago, IL, USA) solution in PBSA. After centrifugation at 2000 x 
g for 20 min, the cell layer containing PBMCs was collected and washed first with PBSA + EDTA 0.1% 
followed with PBSA. The cells were diluted in PBSA, counted using a hemocytometer, and tested for 
viability using Trypan blue exclusion test.		
 
3.2.10 Monocytes 
The monocytes (CD14+) were isolated from isolated PBMCs as described previously (Arsenault 
et al., 2009). Briefly, PBMCs isolated from calf venous blood using Percoll gradients (described above) 
were washed with magnetic activated cell sorting (MACS) running buffer (50ml of 10% BSA, 4 ml of 0.5 
M EDTA and 946 ml of PBSA) and resuspended to a density of 1.25 x 108 cells/ ml. About 2.4 ml of the 
cell suspension was mixed with 600µl of anti-CD14 magnetic microbeads (Miltenyi Biotec Inc., San 
Diego, CA, USA). After incubation at 4°C for 15 min, the cells were washed with MACS running buffer. 
The cell suspension was added to an LS Midi Column (Miltenyi Biotec Inc., San Diego, CA, USA), 
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containing magnetic spheres, attached to a magnet that will allow the positive selection of the cells. Once 
all the cell suspension had passed though the magnetic column, the column was washed three times with 
MACS buffer 5ml\wash).  Next, the columns were removed from the magnets and placed into a sterile 15 
ml conical centrifuge tube (Corning Inc., NY, USA). To obtain the purified cells that remain in the 
column, 5 ml of MACS running buffer was added, and the contents were pushed through the column 
using the plunger provided. The adherent fraction was counted using a hemocytometer, and cell viability 
was assessed using the Trypan blue exclusion test. The purified CD14+ population was coincident in size 
and complexity (FSC and SSC) with bovine monocytes in flow cytometry analysis (data not shown).  
 
3.2.11 In vitro transduction of PBMCs and monocytes  
About 1 x 106 cells per well, plated in 12-well plates (Corning Costar, Corning Inc., NY, USA) in 
500µl AIM-V medium (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) without FBS were 
transduced with indicated amount of BAV304a (Du and Tikoo, 2010) or BAV888 (this study). After 
incubation at 37 °C for 90 mins, 500 µl of AIM-V medium supplemented with 20% FBS was added to 
each well. After incubation for 16 hrs at 37°C, the supernatant from each well was collected and stored at 
-20°C for ELISA assays. After washing with PBSA + 0.1% EDTA, the cells were collected using 
StemPro Accutase Cell Dissociation Reagent (Gibco, Thermo Fisher Scientific, Waltham, MA, USA).  
 
3.2.12 Flow cytometry  
Purified PBMCs and monocytes (CD14+) transduced with BAV304a or BAV888 were 
resuspended in Facola (0.1 M PBS, 0.20/0 gelatin, 0.030/0 NaH3) and plated in a 96-well plate (Corning 
Costar, Corning Inc., NY, USA), with a density of approximately 1 x 106 cells per well. To identify the 
different PBMC populations and activation markers, the cells were incubated with protein specific 
primary antibody (Table 3.1) on ice for 20 min. After washing 3 times with Facola (PBSA supplemented 
with 1% fetal calf serum, 0.09% sodium azide, pH 7.5), the cells were incubated with fluorochrome-
conjugated secondary antibodies (Table 3.2) for 20 min on ice. After 3 washes, the cells were fixed with 
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2% formaldehyde (Sigma-Aldrich, St. Louis, MO, USA) in PBSA and stored at 4°C in the dark. Flow 
cytometry was performed using a FACS Calibur instrument (BD Biosciences, Franklin Lakes, NJ, USA), 
with 10000 events captured per sample. Analysis of flow cytometry data was performed using	Cell Quest 
acquisition and analysis software (BD Biosciences, Franklin Lakes, NJ, USA). 
 
3.2.13 Quantitative RT-PCR  
About 5 x 106 purified bovine monocytes (CD14+) were transduced with BAV304a or BAV888 
at a MOI of 1. At 16 hrs post-infection, the supernatant from each well was collected and centrifuged at 
300 x g for 8 min to collect the floating cells. Meanwhile, TRIzol reagent (Thermo Fisher Scientific, 
Waltham, MA, USA) was added directly to each well containing attached cells. After incubation for 10 
min at room temperature, the TRIzol disrupted cells were collected from each well and added to the 
floating cell pellet obtained above. After adding 0.2 mL of chloroform, the contents were mixed 
vigorously before centrifuging at 14000 x g at 4°C for 15 min. The aqueous phase was collected, 
transferred to a new tube and mixed with an equal volume of 70% ethanol. Finally, RNA was extracted 
using the RNeasy mini kit (Qiagen, Hilden, Germany) as per manufacturer’s instructions. The RNA 
samples were analyzed for quality and quantity using the Agilent 2100 Bioanalyzer (G2938B, Agilent 
Technologies, Santa Clara, CA, USA). Samples with a RNA Integrity Number (RIN) above 7 were used 
to synthesize cDNA using the QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) as per 
manufacturer’s instructions.  
The samples were analyzed with the iCycler iQ PCR detection system (BioRad, CA, USA). Each 
reaction contained 10 ng of cDNA, 0.5 µl of each primer pair at a concentration of 10 µM (Table 3.3), 0.5 
µl of nuclease-free water (Sigma-Aldrich, St. Louis, MO, USA) and 9 µl of PerfeCTa SYBR Green 
SuperMix for iQ (Quanta BioSciences Inc., MD, USA) and the program followed consisted in: 1 cycle at 
50°C for 2 min; 1 cycle at 95°C for 30 secs; 45 cycles of 95°C for 15 sec, 60° for 30 secs and 72°C for 30 
sec. β-actin was used as reference gene, and all reactions were performed in duplicate.  
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Table 3.1: List of primary antibodies used for flow cytometry experiments 
 
 
 
 
Table 3.2: List of secondary antibodies used for flow cytometry experiments 
 
Reactivity Fluorescent 
conjugate 
Target Ig 
class 
Catalog number Supplier 
Rat anti-mouse APC IgG1 17-4015-80 ThermoFisher Scientific 
Goat anti-mouse APC IgG2a 17-4010-82 ThermoFisher Scientific 
Rat anti-mouse APC IgM 550676 BD Biosciences 
 
	
 
 
 
 
Cell surface 
marker  
Isotype Catalog number Supplier 
CD14 IgG1 BOV2109 Washington State University 
CD3 IgG1 BOV2009 Washington State University 
CD21 IgG1 BOV2031 Washington State University 
CD335 IgG1 BOV2147 Washington State University 
CD209 IgG2a BOV2133 Washington State University 
MHC I  IgG2a BOV2120 Washington State University 
MHC II IgG2a BOV2115 Washington State University 
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3.2.14 qPCR assay for viral quantification  
About 2x106 purified bovine monocytes (CD14+) were transduced with BAV304a or BAV888 at 
a MOI of 1. At 16 hrs post-infection, the cells were collected by centrifugation at 300 g for 7 mins and 
resuspended in PBS. The DNA was extracted from the cells using the DNA Blood and Tissue kit (Qiagen, 
Hilden, Germany) as per the manufacturer’s instructions. Finally, the extracted DNA was subjected to 
quantitative PCR using the iCycler iQ PCR detection system (BioRad, CA, USA), using BAdV-3 pVIII 
specific primers (Table 3.3). Viral copy numbers were calculated using a standard curve for wild-type 
BAdV-3 as described earlier (Gaba et al., 2018). 
	
3.2.15 Cytokine detection – ELISA assays  
Supernatants from mock infected or virus infected 5x106 monocytes (CD14+) were collected after 
16 hrs of incubation and stored at -20 °C. The plates were primarily coated with mouse anti-recombinant 
bovine IL-12 (BioRad, CA, USA) or mouse anti-rBoTNFα monoclonal antibody (VIDO-InterVac, SK, 
Canada) in coating buffer (BioRad, CA, USA) and left at 4°C overnight. The next day, plates were 
washed four times with TBST, and standards were added to the plate in two-fold dilutions, followed by 
100ul of the samples, and incubated for 2 hrs at room temperature. After washing again four times with 
TBST, rabbit anti –BoTNFα (VIDO-InterVac, SK, Canada) antibody was added to the TNFα plate. After 
incubation, each plate was washed with TBST and the conjugates were added according to each protocol 
(mouse anti -bovine IL-12 biotin [BioRad, CA, USA] and Goat anti Rabbit IgG (H+L) biotin [Thermo 
Fisher Scientific, Waltham, MA, USA] and incubated for one hour at room temperature. After washing 
with TBST, samples were incubated with streptavidin conjugated alkaline phosphatase (Jackson 
ImmunoResearch Laboratories, PA, USA) for one hr at room temperature. After washing plates (as 
described above), substrate PNPP (Sigma-Aldrich, St. Louis, MO, USA) was added to each well. After 
incubating for 30 mins to one hr at room temperature, the reaction was stopped by adding 0.3M EDTA to 
the plate. Finally, the plates were read using the SpectraMax Plus 384 Microplate Reader (Molecular 
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Devices Corporation, CA, USA) and values for each cytokine were determined from the standard curve 
calculated by the Softmax Pro software (Molecular Devices Corporation, CA, USA). 
 
3.2.16 Statistical analysis 
GraphPad Prism 7 software (La Jolla, CA, USA) was used for statistical analysis of all the data. 
Differences among viruses were assessed with Student t-tests for multiple comparisons. Two-way 
ANOVA was used to determine differences between different MOI and when more than three groups 
where compared in q-RT-PCR and flow cytometry experiments. Differences were considered significant 
with a p-value of less than 0.05. 
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Table 3.3. List of primers 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target gene  Direction Sequence (5’ to 3’) Annealing 
Temperature 
(°C)  
GFP 
Forward 
AAGCTGACCCTGAAGTTCATCTGC 62.4 Reverse CTTGTAGTTGCCGTCGTCCTTGAA 
pVIII 
BAdV-3 
Forward 
CAGGTGCCAGTCAAGATTAC 
52.8 Reverse ATGGCCGACTGAGTCATAAG 
β-actin 
Forward GATCTGGCACCACACCTTCTAC 
57.9 Reverse 
AGGCATACAGGGACAGCACA 
Hexon 
BAdV-3 
Forward TGCTTCTTGCAAACACGACG 61 Reverse 
CCAATCTGAACCCCCGACAA 
19K 
BAdV-3 
Forward 
ATCGCACTGGAGTGTGGAAG 
64.8 Reverse 
GGCACCACAAACACGTCAAA 
52K 
BAdV-3 
Forward 
ACCCTGGGTTTGATGCACTT 59.3 Reverse 
AGCTTCCCCAAAAATGCCCT 
CD40 
Forward 
CTGCCCATATGCCAAGAGTT 56 Reverse 
GGCATCTTCTCTTTCCCCAT 
CD80 
Forward 
ACCACCCAAGCGCCCATG 62.6 Reverse 
AGGCAGGATGGCCAGCAC 
CD86 
Forward 
TGTGCCCTGCAACTTGAGCCA 64.8 Reverse 
AGAGGGGCCAGGCTGCTTCT 
IFNβ 
Forward RTCTGSAGCCAATCCARAAG 
 56.9 Reverse CAGGCACACCTGTYGTACTC 
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3.3 RESULTS 
 
3.3.1 Isolation of recombinant BAV888 
To determine if addition of  an“RGD” motif altered the tropism of BAV304a (E3 deleted BAdV-
3 containing CMV-GFP cassette inserted in E3 region) (Du and Tikoo, 2010), we constructed a plasmid 
pUC304a-CATRGD (Fig. 3.1[a]) containing full length BAV304a genomic clone expressing chimeric 
pIX (C-terminus of pIX fused in frame to a cathepsin cleavage site (ccs) and a RGD motif). Transfection 
of VIDO DT1 cells (cotton rat lung [CRL] expressing I-SceI protein) (Du and Tikoo, 2010) with plasmid 
pUC304a-CATRGD DNA produced cytopathic effects in 15-20 days indicating successful infection. The 
cells showing cytopathic effects (CPEs) and GFP expression were harvested, freeze-thawed three times, 
propagated in MDBK cells and purified by CsCl banding method. As shown in Fig. 3.2 (panel b) 
BAV951 which does not contain cathepsin cleavage sequence between pIX and EYFP (Fig 3.2[a]) 
(Zakhartchouk et al., 2004), the virus particle appeared to be inefficiently released from the endosomes. 
In contrast, BAV888, which contains cathepsin cleavage sequence between pIX and “RGD” motif was 
released efficiently.  
 The identity of recombinant virus named BAV888 was confirmed by sequencing of viral DNA 
and expression of recombinant protein IX was analysed by Western blot using anti- pIX serum 
(Zakhartchouk et al., 2004). As seen in Fig.3.1 (c), anti-pIX detected a 14 kDa protein in BAV304a 
infected cells (lane 2) which is the anticipated size. In contrast, the anticipated 20 kDa protein was 
detected in BAV888 infected cells (lane 3). No such proteins were detected in mock-infected cells (lane 
1).  
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Figure 3.1 Isolation and characterization of BAV304a and BAV888. (a) Schematic diagram of 
genome of BAV304a and BAV888; cathepsin cleavage site (ccs); 10 repeats of glycine-serine (spacer). 
The black box represents the BAdV-3 genome sequence, while the blank space in early (E)-3 region 
represents the deletion of this region. Human cytomegalovirus immediate early gene promoter (CMV); 
Green fluorescent protein (GFP) gene. The direction of the transcription is indicated with arrows. (b) 
Fluorescent microscopy of BAV304a and BAV888 infected cells (c) Western Blot. Proteins from the 
lysates of cell mock-infected (lane 1), BAV304a infected (lane 2) or BAV888 infected (lane 3) were 
separated by 15% SDS-PAGE, transferred to a nitrocellulose membrane and probed in Western blot using 
anti-pIX serum (Zakhartchouk et al., 2004). 
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Figure 3.2 Propagation of BAV888 and BAV951 in MDBK cells. (a) Schematic representation of 
BAV888 and BAV951 genomes; cathepsin cleavage site (ccs); 10 repeats of glycine-serine (spacer). The 
BAdV-3 genome sequence is represented with a black box, while the blank space in early (E)-3 region 
represents the deletion of this region. Human cytomegalovirus immediate early gene promoter (CMV); 
Green fluorescent protein (GFP) gene; Enhanced yellow fluorescent protein (EYFP). The direction of the 
transcription is indicated with arrows. (b) Fluorescent microscopy of BAV888 and BAV951 infected 
MDBK cells. 
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3.3.2 Transduction of peripheral blood mononuclear cells (PBMCs) 
 To establish the optimal concentration of BAV888 required for transduction of bovine PBMCs, 
purified PBMCs from each of the five animals were mock-infected or infected with either BAV304a or 
BAV888 at a MOI 0.2, 0.5, 1 and 2. After a 16-hr post infection, the cells were collected and analyzed by 
flow cytometry. Transduction was assessed as percentage of cells expressing GFP and mean fluorescence 
intensity (MFI) of GFP displayed by each transduced cell.  
As seen in Fig. 3.3 (a), there is a significant difference in transduction of PBMCs between MOI of 0.2 and 
2, irrespective of BAV304a or BAV888. Although more PBMCs appear to be transduced (percentage of 
cells expressing GFP) by BAV888 compared to BAV304a at respective MOIs, there is no significant 
difference in the transduction of PBMCs by indicated viruses at respective MOI (Fig. 3.3[a]). 
Interestingly, there are significant differences between the MFI of PBMCs (intensity of fluorescence 
exhibited by each cell) transduced with BAV888 compared to BAV304a at MOI 0.5, 1 and 2 (Fig. 
3.3[b]). The MFI is three times higher in PBMCs transduced with BAV888 compared to BAV304a at 
MOI 1 and 2. Therefore, the most efficient concentration to use for the next experiment is MOI 1.  
 
3.3.3 Transduction of subpopulations of PBMCs 
To determine if there is any difference in tropism of BAV304a and BAV888 for sub populations 
of PBMCs, we isolated bovine PBMCs from five different animals and transduced them in vitro with 
either BAV304a or BAV888 at MOI 1. After incubating the cells for 16 hrs, the transduced cells were 
incubated with cocktail of antibodies specific for CD3 (T cells), CD14 (monocytes), CD21 (B cells), 
CD335 (NK cells) and CD209 (dendritic cells) surface markers, followed by allophycocyanin (APC) 
conjugated secondary antibody. The labelled cells were analysed by flow cytometry for GFP expression, 
cell marker protein expression, and mean GFP fluorescence intensity. BAV304a transduced about 60% of 
monocytes (CD14+), which correspond to about 6% of the total PBMCs, as seen in Fig. 3.4 (a) and (b). In 
contrast, BAV304a transduced about 35% of dendritic cells (CD209+) (0.21% of PBMCs). However, 
when considering the total number of PBMCs, 2% of the total number of PBMCs correspond to 
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BAV304a-transduced T-cells (CD3+), followed by about 2% NK cells (CD335+) and 1% are transduced 
B-cells (CD21+). Interestingly, there was no significant difference in the transduction of monocytes 
(CD14+),  NK (CD335+) cells,  dendritic cells (209+), T cells ( CD3+) or B cells (CD21+) by BAV304a 
or BAV388. In contrast to the number of GFP positive cells, the mean fluorescence intensity of GFP is 
significantly higher in BAV888 transduced T cells (CD3+) and monocytes (CD14+ cells) compared to 
BAV304a transduced T cells (CD3+) and monocytes (CD14+) (Fig. 3.4 [c]). 
 
3.3.4   Genome copy number in transduced monocytes (CD14+) 
To determine the viral genome copy number, the monocytes (CD14+) cells were purified from 
purified PBMCs using magnetic-activated cell sorting (MACS). The purified monocytes were transduced 
with either BAV304a or BAV888 at MOI 1 and incubated for 16 hrs. The viral DNA present in 
transduced bovine monocytes was analysed by quantitative real time PCR. As seen in Figure 3.5 (a), virus 
genome copy number is significantly higher in monocytes transduced with BAV888 compared to 
monocytes transduced with transduced BAV304a.  
 
3.3.5  Viral gene transcription in transduced monocytes (CD14+) 
To determine the transcription of viral genes, total RNA isolated from MACS purified monocytes 
infected with either BAV304a or BAV888 was analysed by q-RT-PCR using gene specific primers (Table 
3.3). As seen in Fig. 3.5 (panel b), there was significant difference in the level of GFP specific transcripts 
in monocytes transduced with BAV888 compared to monocytes transduced with BAV304a. Similarly, 
there was a significant difference in the level of BAdV-3 19K or hexon-specific transcripts in monocytes 
transduced with BAV888 compared to monocytes transduced with BAV304a. However, there is no 
significant difference in the level of BAdV-3 52K-specific transcripts in monocytes transduced with 
BAV888 compared to monocytes transduced with BAV304a.  
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Figure 3.3 Transduction of bovine PBMCs by BAdV-3. PBMCs were isolated from bovine blood and 
transduced with BAV304a or BAV888 in vitro at MOI 0.2, 0.5, 1 and 2. After 16 hrs post transduction, 
the cells were collected and analyzed by flow cytometry. a) Percentage of GFP positive cells. b) Mean 
fluorescence intensity (MFI) of GFP of each cell analyzed. Data is representative of five independent 
repeats, and it is expressed as mean ±SD. For statistical analysis, the differences between BAV304a and 
BAV888 were analyzed using multiple t-tests, and Two-way ANOVA for differences between MOI, 
using GraphPad Prism 7 (GraphPad Software). 
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Figure 3.4 Transduction of subpopulations of PBMCs by BAdV-3. Bovine PBMCs from five animals 
were isolated from blood and transduced with BAV304a or BAV888 in vitro at MOI 1. After 16 hrs post 
transduction, the cells were collected and stained with antibodies recognizing CD3 (T cells), CD14 
(monocytes), CD21 (B cells), CD335 (NK cells) or CD209 (dendritic cells) surface markers, followed by 
APC conjugated secondary antibodies. The samples were analyzed by flow cytometry, analyzing GFP 
and surface molecules expression in the total PBMC population (a) and percentage of GFP+ cells per 
subpopulation (b), in addition to mean fluorescence intensity (MFI) of GFP (c) of each cell. Data is 
representative of five independent repeats, and it is expressed as mean ±SD. For statistical analysis. The 
differences between BAV304a and BAV888 were analyzed using multiple t-tests, with GraphPad Prism 7 
(GraphPad Software). 
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 There are significant differences in the level of GFP specific transcripts compared to the level of 
BAdV-3 (19k, 52K, hexon) specific transcripts in monocytes transduced with either BAV888 (Fig. 3.5, 
panel c) or BAV304a (Fig. 3.5[d]). Interestingly, unlike monocytes transduced with BAV888, there is no 
significant difference in the BAdV-3 specific transcripts in monocytes transduced with BAV304a (Fig. 
3.5 panel c and d).  
 
3.3.6 Expression of costimulatory molecules and MHC molecules 
 To determine if the transduction of monocytes with either BAV304a or BAV888 can increase the 
expression of MHC molecules, MACS purified monocytes (CD14+) were transduced with either virus at 
a MOI of 1. After 16 hrs post transduction, the cells were stained with anti-MHC I or anti-MHC II 
antibodies, and analysed by flow cytometry. As seen in Figure 3.6 (a), there was no significant difference 
in the expression of MHC class I or class II proteins on the surface of monocytes transduced with either 
BAV304a or BAV388. Similarly, there was no significant difference in the mean GFP fluorescent 
intensity of MHC-II (panel b) or MHC- I (panel c) in monocytes transduced with either BAV304a or 
BAV888. 
 To determine if transduction of monocytes with either BAV304a or BAV888 alter the expression 
of co-stimulatory molecules (CD40, CD80 and CD86), MACS purified monocytes (CD14+) were 
transduced with either virus at a MOI of 1. After 16 hrs post transduction, RNA was isolated and analysed 
by qRT-PCR using gene specific primers. As seen in 3.6 (panel d), there were significant decreases in the 
transcription of CD40 and CD86 mRNAs in monocytes transduced with BAV888 compared to 
untransduced and BAV304a-transduced monocytes. However, there is no difference in the transcription 
of CD80 mRNA in monocytes transduced with either BAV304a or BAV888 or untransduced.  
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Figure 3.5 Viral uptake and gene expression are higher in BAV888-transduced monocytes. Bovine 
CD14+ cells were isolated from bovine blood using MACS and transduced with BAV304a and BAV888 
in vitro at MOI 1. After 16 hours of incubation, cells were collected, and DNA and RNA extraction were 
performed. DNA samples were analyzed with qPCR to obtain the viral copy number, using a standard 
curve for wild-type BAdV-3 (a); the differences between BAV304a and BAV888 were analyzed using 
multiple t-tests. RNA samples were used for transcriptional analysis of GFP and early and late viral 
genes, using RT-qPCR. Ct values of BAV304a and BAV888 genes were normalized with β-actin (ΔCt) 
and represented as 1/ΔCt (b). Gene expression value for BAV304a (c) and BAV888 (d) genes was 
standardized by β-actin gene values (ΔCt) and expressed as 1/ΔCt. Data is representative of three 
independent repeats, and it is expressed as mean ±SD. 
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3.3.7 Production of cytokines in transduced monocytes (CD14+)  
To determine cytokine production in monocytes (CD14+), MACS-purified monocytes were transduced 
with BAV304a or BAV888 at a MOI of 1. After 16 hrs post transduction, the supernatants were collected 
and analyzed for expression of cytokines by capture ELISA (IL-12 and TNF-α) or detection of cytokine 
mRNA by qRT-PCR (IFN-β). As seen in Fig. 3.7, there was a significant increase in the level of TNF-α 
produced by monocytes transduced with BAV888 compared to monocytes transduced with BAV304a 
(panel a). Similarly, the levels of IL-12 were significantly higher in supernatants from monocytes 
transduced with BAV888 compared to monocytes transduced with BAV304a (panel b). Furthermore, the 
level of IFN-β mRNA was significantly higher in monocytes transduced with BAV888 compared to 
monocytes transduced with BAV304a (panel c). 
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Figure 3.6 Activation of co-stimulatory molecules in transduced bovine monocytes. Bovine CD14+ 
cells were transduced with BAV304a and BAV888 in vitro at MOI 1. After 16 hours of incubation, cells 
were collected and stained for flow cytometry, and RNA extraction was also performed. Samples were 
stained with MHC I and MHC II primary antibodies to evaluate the percentage of cells expressing these 
proteins in transduced cells (a) and the differences in the level of expression through MFI of each cell (b 
and c). RNA samples were used for transcriptional analysis of costimulatory molecules CD40, CD80 and 
CD86 using RT-qPCR (d). The Ct values for each gene were normalized by β-actin (ΔCt) and expressed 
as 1/ΔCt. The differences between mock, BAV304a and BAV888 transduced monocytes were analyzed 
using Two-way ANOVA. Data is representative of four independent repeats, and it is expressed as mean ±SD. 
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Figure 3.7 Cytokine production in transduced monocytes. Bovine monocytes were isolated and 
transduced with BAV304a and BAV888 in vitro at MOI 1. After 16 h incubation, the supernatant was 
collected to perform ELISA assays, and RNA was isolated for RT-qPCR. We performed capture ELISA 
against bovine TNFα (a) and IL-12 (b). The data shows to the concentration of cytokines for each virus-
transduced cells – cytokines produced by mock-infected cells (net concentration). RNA samples were 
obtained to analyze the expression of IFNβ (c). The IFNβ gene expression in BAV304a and BAV888 
transduced cells was normalized by β-actin (ΔCt) and expressed as 1/ΔCt. The differences between 
BAV304a and BAV888 were analyzed using multiple t-tests. The differences between mock, BAV304a 
and BAV888 transduced monocytes were analyzed using Two-way ANOVA. Data is representative of 
four independent repeats, and it is expressed as mean ±SD. 
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3.4 DISCUSSION  
 Many viruses including retroviruses, herpes viruses, baculoviruses, and adenoviruses, have 
become very important tools for gene delivery (Maheshri et al., 2006). A number of properties of 
adenovirus (Wilson, 1996),  including efficient transfer of genes in vivo, even to slowly-proliferating or 
non-dividing cells (Graham, 1990; Lemarchand et al., 1992; Rosenfeld et al., 1992; Stratford-Perricaudet 
et al., 1990) has made it attractive as gene delivery vehicle. Although replication-defective recombinant 
human adenovirus-5 has been used in delivering vaccine antigens to mucosal surfaces of cattle, the 
amount of recombinant HAdv-5 required does not appear to result in producing an economical vaccine 
delivery vehicle in cattle (Gogev et al., 2004).  
 One way is to increase the transduction of antigen presenting cells by capsid modified BAdV-3 
vector leading to enhanced availability of vaccine antigen, which can result in the initiation of stronger 
vaccine antigen specific adaptive immune responses. A very good candidate for use of this approach is 
the addition of targeting ligand(s) to C-terminus of minor capsid protein pIX of BAdV-3 which tolerates 
the addition of peptides that could potentially alter the transduction efficiency of BAdV-3 (Zakhartchouk 
et al., 2004). 
 Leukocyte surfaces including antigen presenting cells are rich in integrins that allow them to 
interact with different cell types and structures (Harris et al., 2000; Stewart et al., 1995). In contrast to 
HAdV-5 ( Meier and Greber, 2003 ), BAdV-3 penton protein does not contain “RGD” motif (Reddy et 
al., 1999) suggesting that BAdV-3 internalization may be independent of integrin receptors (Bangari et 
al., 2005). Thus, addition of an “RGD “motif at the C-terminus of BAdV-3 minor capsid protein pIX 
could enhance the ability to the virus to enter the integrin positive APCs (Wu et al., 2002). Here, we 
present the construction and evaluation of recombinant BAdV-3 expressing chimeric pIX (C-terminus of 
pIX fused to RGD motif). Moreover, we demonstrate that recombinant BAV888 (Recombinant BAV304a 
expressing chimeric pIX-RGD) is more efficient than BAV304a (BAdV-3 with GFP cassette in E3 
deleted region) in transducing PBMCs, especially monocytes. 
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 The addition of a cathepsin cleavage site in pIX protein of BAV888 allowed an efficient release 
of the virions from the endosomes, resulting in effective propagation to the adjacent cells. This is also 
supported by comparing BAV888 to BAV951 (BAdV-3 fused with EYFP at C-terminus of minor capsid 
protein pIX) (Zakhartchouk et al., 2004), where the escape of recombinant BAV951 from the endosome 
to the cytoplasm appeared inefficient (Zakhartchouk et al., 2004). Several reports have suggested that 
transduction efficiency of recombinant HAdV-5 displaying a ligand on the surface of virus using C-
terminus of pIX appears inefficient (de Vrij et al., 2008; Campos and Barry, 2006; Corjon et al., 2008). It 
has been proposed that inefficient release of recombinant HAdV-5 particle from the endosome to 
cytoplasm may be due to high -affinity binding of pIX fused ligand and its receptor (Campos and Barry, 
2006). Since cathepsin protease resides in lysozymes, inclusion of cathepsin cleavage sequence between 
pIX and targeting ligand may help in efficient release of virus from endosomes. Therefore, the insertion 
of cathepsin cleavage site between pIX and “RGD” motif resulted in increased transduction by BAV888. 
Similar results have been reported when cathepsin cleavage site has been inserted between pIX and 
targeting ligand in recombinant HAdV-5 (de Vrij et al., 2012).  
Though HAdV-5 entry into the cell involves a primary interaction (fiber with the coxsackievirus-
adenovirus receptor [CAR]) (Bergelson et al., 1997), and a secondary interaction (penton base “RGD” 
with ανβ3 and ανβ5 integrins in the cell surface) (Wickham et al., 1993), little is known about requirement 
of both primary and secondary interactions for BAdV-3 entry in the cells. While primary interaction of 
BAdV-3 fiber with sialic acid has been reported (Li et al., 2009), the nature of the existence of secondary 
interaction is unclear (Bangari et al., 2005). 
Although a slight increase in percent of GFP positive cells could be observed in BAV888 
transduced PBMCs compared to BAV304a transduced PBMCs, the difference does not appear 
significant, suggesting that there is no apparent alteration in the primary interaction of BAdV-3 fiber with 
its receptor. However, there was significant difference in the mean GFP fluorescence intensity in PBMCs 
transduced with recombinant BAV888 compared to PBMCs transduced with BAV304a. This could be 
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due to increased attachment of recombinant BAV888 to PBMCs. Alternatively, it is possible that addition 
of “RGD” motif to pIX facilitated additional interaction with integrin receptors resulting in increased 
entry of recombinant BAV888 in bovine PBMCs.  
 Compared to other PBMC subpopulations, high percentage of GFP positive monocytes 
(CD14+) are detected either in BAV304a or BAV888 infected cells with no significant difference in the 
number of GFP positive cells. Moreover, the mean GFP florescence intensity is significantly higher in 
monocytes transduced with BAV888 compared to monocytes transduced with BAV304a. Similar results 
are observed in T-lymphocytes (CD3+). These results suggest that additional interaction of “RGD” motif 
could result in secondary interaction between “RGD” and cellular integrins, thus modulating the uptake of 
BAV888. A number of observations support this speculation. First, viral genome copies are significantly 
higher in monocytes (CD14+) transduced with BAV888 compared to BAV304a transduced monocytes. 
Secondly, there is significant difference in the detection of GFP and BAdV-3 19K (E1Bsmall region) 
specific transcripts in monocytes (CD14+) transduced with BAV888 compared to monocytes transduced 
with BAV304a. Thirdly, the level of 19K specific transcripts is significantly different than other BAdV-3 
specific transcripts in monocytes transduced with BAV888 compared to monocytes transduced with 
BAV304a.  
These findings are relevant for the development of vaccines, since even though monocytes are not 
considered professional APCs, they can differentiate into macrophages or dendritic cells once they reach 
tissues, and the latter ones can effectively initiate an adaptive immune responses with naïve T cells 
(Steinman and Hemmi, 2006; Trombetta and Mellman, 2005). Moreover, earlier studies suggest that 
immature monocytes themselves can act as APCs, processing antigens, retaining them and presenting 
them to T-cells in the lymph nodes after differentiation to monocyte-derived dendritic cells (Tacke et al., 
2006).  
Analysis of recombinant virus transduced monocyte (CD14+) showed no significant increase in 
the expression of MHC I or MHC II or mean fluorescence intensity of MHC I and II in monocytes 
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transduced with either with BAV304a or BAV888. MHC class I and II molecules play an important role 
in antigen presentation; while MHC I presents intracellular peptides to CD8+ T-cells, MHC II presents 
processed exogenous antigens to CD4+ T-cells (Kurts et al., 2010). Interestingly, some adenoviruses have 
shown the ability to downregulate MHC class I molecules in infected cells, to avoid recognition by CD8+ 
T-cells (Proffitt et al., 1994; Sester et al., 2010). 
Transduction of bovine monocytes with either BAV304a or BAV888 led to significant 
downregulation of CD40 or CD86 specific transcripts compared to un-transduced bovine monocytes. 
However, there was no significant difference in the CD80-specific transcripts in monocytes untransduced 
or transduced with BAV304a or BAV888. Activation of monocytes leads to alterations in the expression 
of activation markers (e.g. CD40, CD80, CD86 etc.). CD40 is expressed in a greater variety of cells, 
including B cells, activated monocytes, and endothelial cells, among others (Grewal & Flavell, 1996). 
The main role of CD40 is in APC activation and in the efficient presentation of the antigen to T-cells 
(Schoenberger et al., 1998). In antigen-presenting cells, the absence of co-stimulatory signals could lead 
to low stimulation of T-cells, leading to decreased proliferative T response or an anergic state (Boussiotis 
et al, 1996; Pinelli et al., 1999).  
Our study show that the level of TNF-α is significantly higher in bovine monocytes transduced 
with BAV888 compared to bovine monocytes transduced with BAV304a. It is possible that higher 
amount of TNF-α detected in BAV888 transduced monocytes could be due to higher number of viral 
genome copies which can trigger an anti-viral immune response. TNF-α appears to be important in 
differentiation of monocyte-to-dendritic cell phenotype (Lyakh et al., 2002). Adenoviruses induce a 
strong innate immune response (Liu & Muruve, 2003) resulting in the induction of inflammatory 
cytokines such as IL-12 and TNFα (Zhang et al., 2001).This early inflammatory response seems to be 
dose-dependent, but it reaches a point of saturation with high viral titers, resulting in no further increases 
in the inflammatory response (Hidaka et al., 1999; Higginbotham et al., 2002).  
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The level of IL-12 protein detected in bovine monocytes transduced with BAV888 was 
significantly higher than bovine monocytes transduced with BAV304a. The presence of IL-12 indicates 
that monocytes in culture were activated, and the higher level of IL-12 expression in BAV888 transduced 
monocytes may indicate a higher level of activation than mock- or BAV304a-transduced monocytes. IL-
12 is be produced by many different cell types including activated monocytes (Hamza et al., 2010), and it 
induces the production of IFN-γ and regulates the induction of type of adaptive immune responses 
(Mosmann et al., 1989). Studies have shown that even the attachment of monocytes to plastic culture 
plates results in their activation (Kelley, 1987).  
The level of IFN-β transcripts were significant higher in bovine monocytes transduced with 
BAV888 compared to bovine monocytes transduced with BAV304a.There is no difference between mock 
and BAV304a induction of IFN-β. This lack of cytokine expression could be due to low viral genome 
uptake. Alternatively, BAV304a could have managed to counteract the anti-viral response by blocking 
induction of an IFN response. Interferon (IFN) type I responses involving IFNα and IFNβ can be induced 
directly in the presence of viruses as primary protection in recently-infected cells (Randall & Goodbourn, 
2008). Adenoviruses have been shown to induce type I interferon in vitro and in- vivo (Huarte et al., 
2006; Zhu et al., 2007). However, recent studies suggest that BAdV-3 protein V can prevent the IFN-β 
promoter activation (Hao, 2017). 
Bovine dendritic cells (CD209+) appear to be permissive to transduction by BAV304a and 
BAV888. Around 40% of the dendritic cells were transduced with both viruses at MOI 1. However, there 
was no significant difference the transduction efficiency or mean GFP fluorescence intensity in bovine 
dendritic cells transduced with either BAV304a or BAV888. Dendritic cells are key components of the 
immune system because they are the only antigen presenting cells capable of priming naïve T-cells 
(Allenspach et al., 2008; Inaba et al., 1990; Trombetta & Mellman, 2005). Because of this characteristic, 
dendritic cells are an optimal target for vaccination, especially when a cellular immune response is 
desirable (Cohn and Delamarre, 2014). It has been demonstrated that HAdV-5 is able to infect human 
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peripheral blood monocyte-derived dendritic cells using lactoferrin and CD209 as primary receptors 
(Adams et al., 2009). Moreover, recent studies have shown that HAdV-5 based vectors can internalize 
bovine skin dendritic cells via actin-dependent endocytosis, which is an alternative pathway to CAR, 
integrins, and other known receptors (Guzman et al., 2016). This integrin-independent mechanism could 
explain the lack of difference in transduction with BAV304a and BAV888. 
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3.5 CONCLUSIONS 
In conclusion, here we describe the transduction efficiency of two recombinant BAdV-3: BAV304a 
(with GFP insertion in E3-deleted region) and BAV888 (with RGD motif in C-terminus of pIX and GFP 
cassette in E3-deleted region) in bovine PBMCs. We have demonstrated that BAV888 is more efficient in 
transducing some bovine PBMCs subtypes than BAV304a. Both viruses seem to have similar tropism for 
the distinct subpopulations, and share a higher percentage of transduction of monocytes. However, data of 
mean fluorescence intensity of GFP and viral copy number show that the viral uptake of BAV888 is 
higher in monocytes compared to BAV304a. This difference in uptake suggests that the addition of an 
RGD motif in the BAdV-3 capsid may enhance its ability to internalize the cells, without interfering with 
the viral tropism.  
Although the transduction of monocytes with either BAV304a or BAV888 do not increase the level 
of costimulatory molecules expressed in the cells, the cytokines pattern suggest that there is an induction 
of innate immune response in monocytes transduced with BAV888, especially because of the 
significantly higher level of IFN-β	 expressed in those cells. Since we demonstrated that BAV888 is 
present in a higher copy number in monocytes than BAV304a, this immune response may be dose-
dependent, which may pose a challenge for clinical use. 
Future studies should further explore if the dose of BAV888 has to be adjusted to avoid an anti-viral 
response against the vector. Since dendritic cells are the most important professional antigen presenting 
cells, the interaction between our recombinant BAV888 and DCs should be further analyzed. In addition, 
the higher MFI in T-cells transduced with BAV888 virus could indicate that there is a higher virus uptake 
in these cells, therefore, the repercussions of this for vaccination or gene therapy could be explored in 
future studies.  Moreover, the insertion of an antigen in BAV888 and immunization in vivo could help to 
analyze the type of immune response generated and if it can deliver vaccine antigens efficiently as a 
recombinant vector.  
 
75	
	
4. REFERENCES 
 
Abbas, A. K., Murphy, K. M., & Sher, A. (1996). Functional diversity of helper T 
lymphocytes. Nature, 383(6603), 787. 
Acheson, N. H. (2011). Fundamentals of molecular virology (No. Ed. 2). John Wiley & Sons, Inc. 
Adams, W. C., Bond, E., Havenga, M. J., Holterman, L., Goudsmit, J., Hedestam, G. B. K., & Lore, K. 
(2009). Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus–adenovirus receptor-
independent receptor pathway mediated by lactoferrin and DC-SIGN. Journal of General Virology, 90(7), 
1600-1610. 
Ahmed, R., & Gray, D. (1996). Immunological memory and protective immunity: understanding their 
relation. Science, 272(5258), 54-60. 
Akalu, A., Liebermann, H., Bauer, U., Granzow, H., & Seidel, W. (1999). The subgenus-specific C-
terminal region of protein IX is located on the surface of the adenovirus capsid. Journal of 
virology, 73(7), 6182-6187. 
Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001). Pulmonary dendritic cells producing IL-10 mediate 
tolerance induced by respiratory exposure to antigen. Nature immunology, 2(8), 725. 
Alemany, R., & Curiel, D. T. (2001). CAR-binding ablation does not change biodistribution and toxicity 
of adenoviral vectors. Gene therapy, 8(17), 1347. 
Allenspach, E. J., Lemos, M. P., Porrett, P. M., Turka, L. A., & Laufer, T. M. (2008). Migratory and 
lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity, 29(5), 795-
806. 
Alt, F. W., Blackwell, T. K., Depinho, R. A., Reth, M. G., & Yancopoulos, G. D. (1986). Regulation of 
genome rearrangement events during lymphocyte differentiation. Immunological reviews, 89(1), 5-30. 
Anand, S. K., Gaba, A., Singh, J., & Tikoo, S. K. (2014). Bovine adenovirus 3 core protein precursor 
pVII localizes to mitochondria, and modulates ATP synthesis, mitochondrial Ca2+ and mitochondrial 
membrane potential. Journal of General Virology, 95(2), 442-452. 
Appaiahgari, M. B., & Vrati, S. (2015). Adenoviruses as gene/vaccine delivery vectors: promises and 
pitfalls. Expert opinion on biological therapy, 15(3), 337-351. 
76	
	
Areschoug, T., & Gordon, S. (2008). Pattern recognition receptors and their role in innate immunity: 
focus on microbial protein ligands. In Trends in Innate Immunity (Vol. 15, pp. 45-60). Karger Publishers. 
Arnberg, N., Edlund, K., Kidd, A. H., & Wadell, G. (2000). Adenovirus type 37 uses sialic acid as a 
cellular receptor. Journal of virology, 74(1), 42-48. 
Arsenault, R. J., Jalal, S., Babiuk, L. A., Potter, A., Griebel, P. J., & Napper, S. (2009). Kinome analysis 
of Toll-like receptor signaling in bovine monocytes. Journal of Receptors and Signal 
Transduction, 29(6), 299-311. 
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., & Geissmann, F. (2007). 
Monitoring of blood vessels and tissues by a population of monocytes with patrolling 
behavior. Science, 317(5838), 666-670. 
Avvakumov, N., Wheeler, R., D'Halluin, J. C., & Mymryk, J. S. (2002). Comparative sequence analysis 
of the largest E1A proteins of human and simian adenoviruses. Journal of virology, 76(16), 7968-7975. 
Ayalew, L. E., Gaba, A., Kumar, P., & Tikoo, S. K. (2014). Conserved regions of bovine adenovirus-3 
pVIII contain functional domains involved in nuclear localization and packaging in mature infectious 
virions. Journal of General Virology, 95(8), 1743-1754. 
Ayalew, L. E., Kumar, P., Gaba, A., Makadiya, N., & Tikoo, S. K. (2015). Bovine adenovirus-3 as a 
vaccine delivery vehicle. Vaccine, 33(4), 493-499. 
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993). B70 
antigen is a second ligand for CTLA-4 and CD28. Nature, 366(6450), 76. 
Backström, E., Kaufmann, K. B., Lan, X., & Akusjärvi, G. (2010). Adenovirus L4-22K stimulates major 
late transcription by a mechanism requiring the intragenic late-specific transcription factor-binding 
site. Virus research, 151(2), 220-228. 
Balato, A., Unutmaz, D., & Gaspari, A. A. (2009). Natural killer T cells: an unconventional T-cell subset 
with diverse effector and regulatory functions. Journal of Investigative Dermatology, 129(7), 1628-1642. 
Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of 
immunity. Nature, 392(6673), 245. 
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., & Palucka, K. (2000). 
Immunobiology of dendritic cells. Annual review of immunology, 18(1), 767-811 
77	
	
Bangari, D. S., & Mittal, S. K. (2006). Development of nonhuman adenoviruses as vaccine 
vectors. Vaccine, 24(7), 849-862. 
Bangari, D. S., Sharma, A., & Mittal, S. K. (2005). Bovine adenovirus type 3 internalization is 
independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. Biochemical 
and biophysical research communications, 331(4), 1478-1484. 
Bangari, D. S., Shukla, S., & Mittal, S. K. (2005). Comparative transduction efficiencies of human and 
nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochemical and 
biophysical research communications, 327(3), 960-966. 
Barouch, D. H., Kik, S. V., Weverling, G. J., Dilan, R., King, S. L., Maxfield, L. F., & de Bruyn, G. 
(2011). International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult 
populations. Vaccine, 29(32), 5203-5209 
Bartha, A. (1969). Proposal for subgrouping of bovine adenoviruses. Acta Vet Budapest. 
Batista, F. D., & Harwood, N. E. (2009). The who, how and where of antigen presentation to B 
cells. Nature Reviews Immunology, 9(1), 15. 
Baxi, M. K., Reddy, P. S., Zakhartchouk, A. N., Idamakanti, N., Pyne, C., Babiuk, L. A., & Tikoo, S. K. 
(1998). Characterization of bovine adenovirus type 3 early region 2B. Virus genes, 16(3), 313-316. 
Baxi, M. K., Deregt, D., Robertson, J., Babiuk, L. A., Schlapp, T., & Tikoo, S. K. (2000). Recombinant 
bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune 
response in cotton rats. Virology, 278(1), 234-243. 
Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., & Ziegler-
Heitbrock, L. (2002). The proinflammatory CD14+ CD16+ DR++ monocytes are a major source of 
TNF. The Journal of Immunology, 168(7), 3536-3542. 
Bell, D., Young, J. W., & Banchereau, J. (1999). Dendritic cells. In Advances in immunology (Vol. 72, 
pp. 255-324). Academic Press. 
Belz, G. T., & Nutt, S. L. (2012). Transcriptional programming of the dendritic cell network. Nature 
Reviews Immunology, 12(2), 101. 
Benkő, M. (2008). Adenoviruses: Pathogenesis. Encyclopedia of Virology 
78	
	
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., & 
Finberg, R. W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 
5. Science, 275(5304), 1320-1323. 
Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of 
leukocyte biology, 81(1), 1-5. 
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999). Natural killer 
cells in antiviral defense: function and regulation by innate cytokines. Annual review of 
immunology, 17(1), 189-220. 
Biron, C. A., Dalod, M., & Salazar-Mather, T. P. (2002). Innate immunity and viral infections. 
In Immunology of infectious diseases (pp. 139-160). American Society of Microbiology. 
Bluman, E. M., Bartynski, K. J., Avalos, B. R., & Caligiuri, M. A. (1996). Human natural killer cells 
produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived 
cytokines. The Journal of clinical investigation, 97(12), 2722-2727. 
Bodrova, O. S. (2010). Evaluation and correction of the immune status of cows with high milk 
production. Lead. Sci. Russ. abroad 439–442. 
Bonilla, F. A., & Oettgen, H. C. (2010). Adaptive immunity. Journal of Allergy and Clinical 
Immunology, 125(2), S33-S40. 
Bosher, J., Robinson, E. C., & Hay, R. T. (1990). Interactions between the adenovirus type 2 DNA 
polymerase and the DNA binding domain of nuclear factor I. The New biologist, 2(12), 1083-1090. 
Boulanger, P., Lemay, P., Blair, G. E., & Russell, W. C. (1979). Characterization of adenovirus protein 
IX. Journal of General Virology, 44(3), 783-800. 
Bremner, K. H., Scherer, J., Yi, J., Vershinin, M., Gross, S. P., & Vallee, R. B. (2009). Adenovirus 
transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell host & 
microbe, 6(6), 523-535. 
Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M., & Dörken, B. (1997). Liver-
associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer gene therapy, 4(1), 9-
16. 
Brignier, A. C., & Gewirtz, A. M. (2010). Embryonic and adult stem cell therapy. Journal of Allergy and 
Clinical Immunology, 125(2), S336-S344. 
79	
	
Brown, W. C., Davis, W. C., Choi, S. H., Dobbelaere, D. A., & Splitter, G. A. (1994). Functional and 
phenotypic characterization of WC1+ γ/δ T cells isolated from Babesia bovis-stimulated T cell 
lines. Cellular immunology, 153(1), 9-27. 
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004). Acute 
toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman 
primates. Human gene therapy, 15(1), 35-46. 
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., & McElrath, M. J. 
(2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, 
randomised, placebo-controlled, test-of-concept trial. The Lancet, 372(9653), 1881-1893. 
Byersdorfer, C. A., & Chaplin, D. D. (2001). Visualization of early APC/T cell interactions in the mouse 
lung following intranasal challenge. The Journal of Immunology, 167(12), 6756-6764. 
Cai, F. X., Bourbonnière, M., Tang, D., Hu, S. L., & Weber, J. M. (1990). Nucleotide and deduced amino 
acid sequence of the bovine adenovirus type 3 proteinase. Nucleic acids research, 18(18), 5568. 
Campos, S. K., & Barry, M. A. (2006). Comparison of adenovirus fiber, protein IX, and hexon 
capsomeres as scaffolds for vector purification and cell targeting. Virology, 349(2), 453-462. 
Capra, J. D., Janeway, C. A., Travers, P., & Walport, M. (1999). Inmunobiology: the inmune system in 
health and disease. Garland Publishing. 
Carroll, J. A., & Forsberg, N. E. (2007). Influence of stress and nutrition on cattle immunity. Veterinary 
Clinics: Food Animal Practice, 23(1), 105-149. 
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996). 
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T 
cell stimulatory capacity: TT help via APC activation. Journal of Experimental Medicine, 184(2), 747-
752. 
Cella, M., Sallusto, F., & Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of 
dendritic cells. Current opinion in immunology, 9(1), 10-16. 
Cepko, C. L., & Sharp, P. A. (1982). Assembly of adenovirus major capsid protein is mediated by a 
nonvirion protein. Cell, 31(2), 407-415. 
80	
	
Challberg, M. D., Desiderio, S. V., & Kelly, T. J. (1980). Adenovirus DNA replication in vitro: 
characterization of a protein covalently linked to nascent DNA strands. Proceedings of the National 
Academy of Sciences, 77(9), 5105-5109. 
Chang, M. D. Y., Stanley, E. R., Khalili, H., Chisholm, O., & Pollard, J. W. (1995). Osteopetrotic (op/op) 
mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune 
response. Cellular immunology, 162(1), 146-152. 
Chaplin, D. D. (2010). Overview of the immune response. Journal of Allergy and Clinical 
Immunology, 125(2), S3-S23. 
Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., & Mehtali, M. (1996). Efficient 
generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. Journal 
of virology, 70(7), 4805-4810. 
Chase, J. W., & Williams, K. R. (1986). Single-stranded DNA binding proteins required for DNA 
replication. Annual review of biochemistry, 55(1), 103-136. 
Chatila, T. A. (2005). Role of regulatory T cells in human diseases. Journal of Allergy and Clinical 
Immunology, 116(5), 949-959. 
Chiocca, S., Kurzbauer, R., Schaffner, G., Baker, A., Mautner, V., & Cotten, M. (1996). The complete 
DNA sequence and genomic organization of the avian adenovirus CELO. Journal of virology, 70(5), 
2939-2949. 
Chu, Y., Heistad, D. D., Cybulsky, M. I., & Davidson, B. L. (2001). Vascular cell adhesion molecule-1 
augments adenovirus-mediated gene transfer. Arteriosclerosis, thrombosis, and vascular biology, 21(2), 
238-242. 
Chung, J. B., Silverman, M., & Monroe, J. G. (2003). Transitional B cells: step by step towards immune 
competence. Trends in immunology, 24(6), 342-348. 
Cohn, L., & Delamarre, L. (2014). Dendritic cell-targeted vaccines. Frontiers in immunology, 5, 255. 
Colby, W. W., & Shenk, T. (1981). Adenovirus type 5 virions can be assembled in vivo in the absence of 
detectable polypeptide IX. Journal of virology, 39(3), 977-980. 
Cooper, M. D., & Alder, M. N. (2006). The evolution of adaptive immune systems. Cell, 124(4), 815-
822. 
81	
	
Coutinho, A., & Möller, G. (1975). Thymus-Independent B-Cell Induction and Paralysis1. In Advances in 
immunology (Vol. 21, pp. 113-236). Academic Press. 
Crisostomo, L., Soriano, A. M., Frost, J. R., Olanubi, O., Mendez, M., & Pelka, P. (2017). The Influence 
of E1A C-Terminus on Adenovirus Replicative Cycle. Viruses, 9(12), 387. 
Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S. Y., Senechal, B., & Jais, J. P. (2010). Human 
CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 
receptors. Immunity, 33(3), 375-386. 
Crosby, C. M., Nehete, P., Sastry, K. J., & Barry, M. A. (2014). Amplified and persistent immune 
responses generated by single cycle replicating adenovirus vaccines. Journal of virology, JVI-02184. 
Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., & Chien, Y. H. (1998). Ligand 
recognition by αβ T cell receptors. Annual review of immunology, 16(1), 523-544. 
Davison, A. J., Benkő, M., & Harrach, B. (2003). Genetic content and evolution of adenoviruses. Journal 
of General Virology, 84(11), 2895-2908. 
Debbas, M., & White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by 
E1B. Genes & development, 7(4), 546-554. 
Dechecchi, M. C., Tamanini, A., Bonizzato, A., & Cabrini, G. (2000). Heparan sulfate 
glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology, 268(2), 382-
390. 
Defer, C., Belin, M. T., Caillet-Boudin, M. L., & Boulanger, P. (1990). Human adenovirus-host cell 
interactions: comparative study with members of subgroups B and C. Journal of virology, 64(8), 3661-
3673. 
de Jong, R. N., van der Vliet, P. C., & Brenkman, A. B. (2003). Adenovirus DNA replication: protein 
priming, jumping back and the role of the DNA binding protein DBP. In Adenoviruses: Model and 
Vectors in Virus-Host Interactions (pp. 187-211). Springer, Berlin, Heidelberg. 
de Jong, E. C., Smits, H. H., & Kapsenberg, M. L. (2005). Dendritic cell-mediated T cell polarization. 
In Springer seminars in immunopathology (Vol. 26, No. 3, pp. 289-307). Springer-Verlag. 
de Vrij, J., Uil, T. G., Van Den Hengel, S. K., Cramer, S. J., Koppers-Lalic, D., Verweij, M. C., & 
Hoeben, R. C. (2008). Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a 
single-chain T-cell receptor with minor capsid protein IX. Gene therapy, 15(13), 978. 
82	
	
de Vrij, J., Dautzenberg, I. J. C., Van den Hengel, S. K., Magnusson, M. K., Uil, T. G., Cramer, S. J., ... & 
Hoeben, R. C. (2012). A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-
targeting ligand improves targeted transduction. Gene therapy, 19(9), 899. 
Dekker, J., Kanellopoulos, P. N., Loonstra, A. K., van Oosterhout, J. A., Leonard, K., Tucker, P. A., & 
van der Vliet, P. C. (1997). Multimerization of the adenovirus DNA-binding protein is the driving force 
for ATP-independent DNA unwinding during strand displacement synthesis. The EMBO journal, 16(6), 
1455-1463. 
Delamarre, L., Pack, M., Chang, H., Mellman, I., & Trombetta, E. S. (2005). Differential lysosomal 
proteolysis in antigen-presenting cells determines antigen fate. Science, 307(5715), 1630-1634. 
Delves, P. J., Martin, S. J., & Burton, D. R. (2001). Roitt's Essential Immunology (Essentials). 
Desiderio, S. V. (1992). B-cell activation. Current opinion in immunology, 4(3), 252-256. 
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., & Moser, M. (1996). 
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. Journal of 
Experimental Medicine, 184(4), 1413-1424. 
DiLillo, D. J., Hamaguchi, Y., Ueda, Y., Yang, K., Uchida, J., Haas, K. M., & Tedder, T. F. (2008). 
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell 
depletion during CD20 immunotherapy in mice. The Journal of Immunology, 180(1), 361-371. 
Dmitriev, I. P., Kashentseva, E. A., & Curiel, D. T. (2002). Engineering of adenovirus vectors containing 
heterologous peptide sequences in the C terminus of capsid protein IX. Journal of virology, 76(14), 6893-
6899. 
Drannik, G. N. (2003). Clinical Immunology and Allergology. Moscow: MIA. 
D'Souza, C. D., Cooper, A. M., Frank, A. A., Mazzaccaro, R. J., Bloom, B. R., & Orme, I. M. (1997). An 
anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium 
tuberculosis. The Journal of Immunology, 158(3), 1217-1221. 
Du, E., & Tikoo, S. K. (2010). Efficient replication and generation of recombinant bovine adenovirus-3 in 
nonbovine cotton rat lung cells expressing I-SceI endonuclease. The journal of gene medicine, 12(10), 
840-847. 
Dustin, M. L., & Cooper, J. A. (2000). The immunological synapse and the actin cytoskeleton: molecular 
hardware for T cell signaling. Nature immunology, 1(1), 23. 
83	
	
Dutton, R. W., Bradley, L. M., & Swain, S. L. (1998). T cell memory. Annual review of 
immunology, 16(1), 201-223. 
Düvel, A., Maaß, J., Heppelmann, M., Hussen, J., Koy, M., Piechotta, M., & Zieger, P. (2014). Peripheral 
blood leukocytes of cows with subclinical endometritis show an altered cellular composition and gene 
expression. Theriogenology, 81(7), 906-917. 
Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J., & MacDonald, H. R. (1999). Tissue-
specific segregation of CD1d-dependent and CD1d-independent NK T cells. The Journal of 
Immunology, 162(11), 6410-6419. 
e Sousa, C. R., Yap, G., Schulz, O., Rogers, N., Schito, M., Aliberti, J., & Sher, A. (1999). Paralysis of 
dendritic cell IL-12 production by microbial products prevents infection-induced 
immunopathology. Immunity, 11(5), 637-647. 
ÉlŐ, P., Farkas, S. L., Dán, Á. L., & Kovacs, G. M. (2003). The p32K structural protein of the 
atadenovirus might have bacterial relatives. Journal of molecular evolution, 56(2), 175-180. 
Enders, J. F., Bell, J. A., Dingle, J. H., Francis Jr, T., Hilleman, M. R., Huebner, R. J., & Payne, A. M. M. 
(1956). "Adenoviruses": Group name proposed for new respiratory-tract viruses. Science (Washington), 
124, 119-20. 
Epstein, M. M., Di Rosa, F., Jankovic, D., Sher, A., & Matzinger, P. (1995). Successful T cell priming in 
B cell-deficient mice. Journal of Experimental Medicine, 182(4), 915-922. 
Everitt, E., & Philipson, L. (1974). Structural proteins of adenoviruses: XI. Purification of three low 
molecular weight virion proteins of adenovirus type 2 and their synthesis during productive 
infection. Virology, 62(1), 253-269. 
Fagraeus, A. (1948). The plasma cellular reaction and its relation to the formation of antibodies in 
vitro. Journal of immunology, 58(1), 1-13. 
Faria, A. M., & Weiner, H. L. (1999). Oral tolerance: mechanisms and therapeutic applications. 
In Advances in immunology (Vol. 73, pp. 153-264). Academic Press. 
Fearon, D. T., & Locksley, R. M. (1996). The instructive role of innate immunity in the acquired immune 
response. Science, 272(5258), 50-54. 
84	
	
Fischer, L., Tronel, J. P., Pardo-David, C., Tanner, P., Colombet, G., Minke, J., & Audonnet, J. C. (2002). 
Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a 
canine distemper virus challenge. Vaccine, 20(29-30), 3485-3497. 
Fitzgerald, J. C., Gao, G. P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., & Ertl, H. 
C. (2003). A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. The Journal of 
Immunology, 170(3), 1416-1422. 
Frankenberger, M., Sternsdorf, T., Pechumer, H., Pforte, A., & Ziegler-Heitbrock, H. W. (1996). 
Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction 
analysis. Blood, 87(1), 373-377. 
Fries, P., Popowych, Y. I., Beskorwayne, T., Potter, A., Babiuk, L., & Griebel, P. J. (2011). Mucosal 
dendritic cell subpopulations in the small intestine of newborn calves. Developmental & Comparative 
Immunology, 35(10), 1040-1051. 
Furcinitti, P. S., Oostrum, J., & Burnett, R. M. (1989). Adenovirus polypeptide IX revealed as capsid 
cement by difference images from electron microscopy and crystallography. The EMBO journal, 8(12), 
3563-3570. 
Gaba, A., Ayalew, L., Makadiya, N., & Tikoo, S. (2017). Proteolytic cleavage of bovine adenovirus 3-
encoded pVIII. Journal of virology, 91(10), e00211-17. 
Gaba, A., Ayalew, L. E., Patel, A., Kumar, P., & Tikoo, S. K. (2018). Bovine Adenovirus-3 Protein VIII 
associates with eukaryotic initiation factor-6 during infection. Cellular microbiology, e12842. 
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003). CD46 is a cellular receptor for group B 
adenoviruses. Nature medicine, 9(11), 1408. 
Gahéry-Ségard, H., Farace, F., Godfrin, D., Gaston, J., Lengagne, R., Tursz, T., & Guillet, J. G. (1998). 
Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base 
antibodies have a synergistic effect on neutralizing activity. Journal of virology, 72(3), 2388-2397. 
Galaktionov, V. G. (2005). Evolutionary Immunology. Moscow: ICC Akadem Kniga 
Gallucci, S., & Matzinger, P. (2001). Danger signals: SOS to the immune system. Current opinion in 
immunology, 13(1), 114-119. 
85	
	
Gazizova, A. I. (2001). Age-related characteristics of the spleen lymphatic system structure in mammals. 
In: Proceedings of the International Scientific-Practical Conference of Morphologists Commemorating 
(J. F. Yudichev, ed.) pp. 117–120. 
Gazizova, A. I., & A. B. Atkenova. (2015). Morphofunctional state of thymus in cattle as a lymphoid 
organ. Sci. World 1, 48–50. 
Gazizova, A. I., & L. M. Murzabekova. (2007) Macro-microscopic spleen structure in mammals. In: 
Proceedings of the International Scientific and Practical Conference Dedicated to the 50th Anniversary 
of the “S.Seifullin KazATU” Foundation. pp. 180–182. 
Geissmann, F., Gordon, S., Hume, D. A., Mowat, A. M., & Randolph, G. J. (2010). Unravelling 
mononuclear phagocyte heterogeneity. Nature Reviews Immunology, 10(6), 453. 
Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands 
for T lymphocyte activation. Cell, 76(2), 287-299. 
Ghirotti, M., Semproni, G., De Meneghi, D., Mungaba, F. N., Nannini, D., Calzetta, G., & Paganico, G. 
(1991). Sero-prevalences of selected cattle diseases in the Kafue flats of Zambia. Veterinary research 
communications, 15(1), 25-36. 
Ghosh-Choudhury, G., Haj-Ahmad, Y., & Graham, F. L. (1987). Protein IX, a minor component of the 
human adenovirus capsid, is essential for the packaging of full length genomes. The EMBO journal, 6(6), 
1733-1739. 
Ginsberg, H. S., Badger, G. F., Dingle, J. H., Jordan Jr, W. S., & Katz, S. (1955). Etiologic relationship of 
the RI-67 agent to “acute respiratory disease (ARD).” Journal of Clinical Investigation, 34(6), 820. 
Gogev, S., Georgin, J. P., Schynts, F., Vanderplasschen, A., & Thiry, E. (2004). Bovine herpesvirus 1 
glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 
5. Veterinary research, 35(6), 715-721. 
González-Cano, P., Arsic, N., Popowych, Y. I., & Griebel, P. J. (2014). Two functionally distinct myeloid 
dendritic cell subpopulations are present in bovine blood. Developmental & Comparative 
Immunology, 44(2), 378-388. 
Gorman, J. J., Wallis, T. P., Whelan, D. A., Shaw, J., & Both, G. W. (2005). LH3, a “homologue” of the 
mastadenoviral E1B 55-kDa protein is a structural protein of atadenoviruses. Virology, 342(1), 159-166. 
86	
	
Graham, F. L. (1990). Adenoviruses as expression vectors and recombinant vaccines. Trends in 
biotechnology, 8, 85-87. 
Grand, R. J. (1987). The structure and functions of the adenovirus early region 1 proteins. Biochemical 
Journal, 241(1), 25. 
Gray, G., Buchbinder, S., & Duerr, A. (2010). Overview of STEP and Phambili trial results: two phase 
IIb test of concept studies investigating the efficacy of MRK ad5 gag/pol/nef sub-type B HIV 
vaccine. Current opinion in HIV and AIDS, 5(5), 357. 
Grewal, I. S., & Flavell, R. A. (1996). The Role of CD40 Ligand in Costimulation and T-Cell 
Activation. Immunological reviews, 153(1), 85-106. 
Gridnev, V. A., & V. V. Mironov. (2003). Immunity – Security System of the Organism. Methodological 
Recommendations. Tambov: Publishing House of Tambov State Technological University 
Griebel, P. J., & Hein, W. R. (1996). Expanding the role of Peyer's patches in B-cell 
ontogeny. Immunology today, 17, 30-38. 
Guzman, E., Hope, J., Taylor, G., Smith, A. L., Cubillos-Zapata, C., & Charleston, B. (2014). Bovine γδ 
T cells are a major regulatory T cell subset. The Journal of Immunology, 1303398. 
Guzman, E., Taylor, G., Hope, J., Herbert, R., Cubillos-Zapata, C., & Charleston, B. (2016). Transduction 
of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic 
pathway. Journal of General Virology, 97(10), 2703-2718. 
Hammarskjöld, M. L., & Winberg, G. (1980). Encapsidation of adenovirus 16 DNA is directed by a small 
DNA sequence at the left end of the genome. Cell, 20(3), 787-795. 
Hamza, T., Barnett, J. B., & Li, B. (2010). Interleukin 12 a key immunoregulatory cytokine in infection 
applications. International journal of molecular sciences, 11(3), 789-806. 
Harrach, B. (2008). Adenoviruses: General Features. Encyclopedia of Virology. 
Harris, E. S., McIntyre, T. M., Prescott, S. M., & Zimmerman, G. A. (2000). The leukocyte 
integrins. Journal of Biological Chemistry, 275(31), 23409-23412. 
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., & Lund, F. E. (2000). 
Reciprocal regulation of polarized cytokine production by effector B and T cells. Nature 
immunology, 1(6), 475. 
87	
	
Hartmann, G., & Krieg, A. M. (2000). Mechanism and function of a newly identified CpG DNA motif in 
human primary B cells. The Journal of Immunology, 164(2), 944-953. 
Hearing, P., Samulski, R. J., Wishart, W. L., & Shenk, T. (1987). Identification of a repeated sequence 
element required for efficient encapsidation of the adenovirus type 5 chromosome. Journal of 
virology, 61(8), 2555-2558. 
Hess, M., Blöcker, H., & Brandt, P. (1997). The complete nucleotide sequence of the egg drop syndrome 
virus: an intermediate between mastadenoviruses and aviadenoviruses. Virology, 238(1), 145-156. 
Hidaka, C., Milano, E., Leopold, P. L., Bergelson, J. M., Hackett, N. R., Finberg, R. W., & Crystal, R. G. 
(1999). CAR-dependent and CAR-independent pathways of adenovirus vector–mediated gene transfer 
and expression in human fibroblasts. The Journal of clinical investigation, 103(4), 579-587. 
Higginbotham, J. N., Seth, P., Blaese, R. M., & Ramsey, W. J. (2002). The release of inflammatory 
cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus 
variants and capsid. Human gene therapy, 13(1), 129-141. 
Hilleman, M. R., & Werner, J. H. (1954). Recovery of new agent from patients with acute respiratory 
illness. Proceedings of the Society for Experimental Biology and Medicine, 85(1), 183-188. 
Hoek, A., Rutten, V. P., Kool, J., Arkesteijn, G. J., Bouwstra, R. J., Van, I. R., & Koets, A. P. (2009). 
Subpopulations of bovine WC1 (+) gammadelta T cells rather than CD4 (+) CD25 (high) Foxp3 (+) T 
cells act as immune regulatory cells ex vivo. Veterinary research, 40(1), 6-6. 
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., & Taniguchi, T. (2005). IRF-7 is 
the master regulator of type-I interferon-dependent immune responses. Nature, 434(7034), 772. 
Hong, S. S., Karayan, L., Tournier, J., Curiel, D. T., & Boulanger, P. A. (1997). Adenovirus type 5 fiber 
knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. The 
EMBO journal, 16(9), 2294-2306. 
Honkavuori, K. S., Pollard, B. D., Rodriguez, M. S., Hay, R. T., & Kemp, G. D. (2004). Dual role of the 
adenovirus pVI C terminus as a nuclear localization signal and activator of the viral protease. Journal of 
general virology, 85(11), 3367-3376. 
Hori, S., Nomura, T., & Sakaguchi, S. (2003). Control of regulatory T cell development by the 
transcription factor Foxp3. Science, 299(5609), 1057-1061. 
88	
	
Horwitz, M. S. (2004). Function of adenovirus E3 proteins and their interactions with immunoregulatory 
cell proteins. The journal of gene medicine, 6(S1). 
Huebner, R. J., Rowe, W. P., Ward, T. G., Parrott, R. H., & Bell, J. A. (1954). Adenoidal-pharyngeal-
conjunctival agents: a newly recognized group of common viruses of the respiratory system. New 
England Journal of Medicine, 251(27), 1077-1086. 
Hussen, J., Düvel, A., Sandra, O., Smith, D., Sheldon, I. M., Zieger, P., & Schuberth, H. J. (2013). 
Phenotypic and functional heterogeneity of bovine blood monocytes. PLoS One, 8(8), e71502. 
Inaba, K., Metlay, J. P., Crowley, M. T., & Steinman, R. M. (1990). Dendritic cells pulsed with protein 
antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. Journal of Experimental 
Medicine, 172(2), 631-640. 
Inaba, K., Inaba, M., Naito, M., & Steinman, R. M. (1993). Dendritic cell progenitors phagocytose 
particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens 
in vivo. Journal of Experimental Medicine, 178(2), 479-488. 
Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., & Muramatsu, S. 
(1994). The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in 
situ and during maturation in vitro. Journal of Experimental Medicine, 180(5), 1849-1860. 
Ingulli, E., Mondino, A., Khoruts, A., & Jenkins, M. K. (1997). In vivo detection of dendritic cell antigen 
presentation to CD4+ T cells. Journal of Experimental Medicine, 185(12), 2133-2141. 
Itano, A. A., & Jenkins, M. K. (2003). Antigen presentation to naive CD4 T cells in the lymph 
node. Nature immunology, 4(8), 733. 
Itano, A. A., McSorley, S. J., Reinhardt, R. L., Ehst, B. D., Ingulli, E., Rudensky, A. Y., & Jenkins, M. K. 
(2003). Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate 
different aspects of cell-mediated immunity. Immunity, 19(1), 47-57. 
Janeway, C. A. (1989). Approaching the asymptote? Evolution and revolution in immunology. In Cold 
Spring Harbor symposia on quantitative biology (Vol. 54, pp. 1-13). Cold Spring Harbor Laboratory 
Press. 
Janeway, C. A., Travers, P., Walport, M., & Shlomchik, M. J. (2005). Immunobiology: the immune 
system in health and disease. 
89	
	
Jenkins, M. K., Khoruts, A., Ingulli, E., Mueller, D. L., McSorley, S. J., Reinhardt, R. L., & Pape, K. A. 
(2001). In vivo activation of antigen-specific CD4 T cells. Annual review of immunology, 19(1), 23-45. 
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009). Inflammatory signals in dendritic cell 
activation and the induction of adaptive immunity. Immunological reviews, 227(1), 234-247. 
Joncker, N. T., & Raulet, D. H. (2008). Regulation of NK cell responsiveness to achieve self-tolerance 
and maximal responses to diseased target cells. Immunological reviews, 224(1), 85-97. 
Jones, J. W., Kayagaki, N., Broz, P., Henry, T., Newton, K., O'Rourke, K., & Dixit, V. M. (2010). Absent 
in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proceedings of the 
National Academy of Sciences, 107(21), 9771-9776. 
Kabelitz, D., Peters, C., Wesch, D., & Oberg, H. H. (2013). Regulatory functions of γδ T 
cells. International immunopharmacology, 16(3), 382-387. 
Kaisho, T., & Akira, S. (2006). Toll-like receptor function and signaling. Journal of allergy and clinical 
immunology, 117(5), 979-987. 
Kapitonov, M. Y., O. V. Fedorov, Z. C. Morozova. (2005). Quantitative immunohistochemical evaluation 
of post-stress changes in the thymus of the growing organism. Success. Mod. Sci. 2, 92–111. 
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., & Akira, S. (2005). IPS-1, an adaptor 
triggering RIG-I-and Mda5-mediated type I interferon induction. Nature immunology, 6(10), 981. 
Keßler, T., Hamprecht, K., Feuchtinger, T., & Jahn, G. (2010). Dendritic cells are susceptible to infection 
with wild-type adenovirus, inducing a differentiation arrest in precursor cells and inducing a strong T-cell 
stimulation. Journal of General Virology, 91(5), 1150-1154. 
Kelkar, S., De, B. P., Gao, G., Wilson, J. M., Crystal, R. G., & Leopold, P. L. (2006). A common 
mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus 
and adenovirus serotypes. Journal of virology, 80(15), 7781-7785. 
Khare, R., Y Chen, C., A Weaver, E., & A Barry, M. (2011). Advances and future challenges in 
adenoviral vector pharmacology and targeting. Current gene therapy, 11(4), 241-258. 
Khosa, S. (2017). Transduction of bovine blood cells with recombinant bovine adenovirus-3 expressing 
green fluorescent protein (Unpublished master’s thesis). University of Saskatchewan, Saskatoon, Canada.  
Kierszenbaum, A. L., & Tres, L. (2015). Histology and Cell Biology: An Introduction to Pathology E-
Book. Elsevier Health Sciences. 
90	
	
Kim, J. V., Latouche, J. B., Rivière, I., & Sadelain, M. (2004). The ABCs of artificial antigen 
presentation. Nature biotechnology, 22(4), 403. 
King, A. M., Lefkowitz, E., Adams, M. J., & Carstens, E. B. (Eds.) (2011). Virus taxonomy: ninth report 
of the International Committee on Taxonomy of Viruses. Elsevier. 
Kitchingman, G. R. (1985). Sequence of the DNA-binding protein of a human subgroup E adenovirus 
(type 4): comparisons with subgroup A (type 12), subgroup B (type 7), and subgroup C (type 
5). Virology, 146(1), 90-101. 
Klein, M., Earley, E., & Zellat, J. (1959). Isolation from cattle of a virus related to human 
adenovirus. Proceedings of the Society for Experimental Biology and Medicine, 102(1), 1-4. 
Koch, N. F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kämpgen, E., & Schuler, G. (1996). High 
level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and 
downregulation by IL-4 and IL-10. Journal of Experimental Medicine, 184(2), 741-746. 
Kondrakhin, I. P. (2004). Methods of Veterinary Clinical Laboratory Diagnostics: Reference Book. 
Moscow: Colossus. 
Kovács, E. R., & Benkő, M. (2009). Confirmation of a novel siadenovirus species detected in raptors: 
partial sequence and phylogenetic analysis. Virus research, 140(1-2), 64-70. 
Kovács, G. M., LaPatra, S. E., D’Halluin, J. C., & Benkő, M. (2003). Phylogenetic analysis of the hexon 
and protease genes of a fish adenovirus isolated from white sturgeon (Acipenser transmontanus) supports 
the proposal for a new adenovirus genus. Virus research, 98(1), 27-34. 
Kudo, S., Matsuno, K., Ezaki, T., & Ogawa, M. (1997). A novel migration pathway for rat dendritic cells 
from the blood: hepatic sinusoids–lymph translocation. Journal of Experimental Medicine, 185(4), 777-
784. 
Kulshreshtha, V., Islam, A., Ayalew, L. E., & Tikoo, S. K. (2015). Leucine residues in conserved region 
of 33K protein of bovine adenovirus–3 are important for binding to major late promoter and activation of 
late gene expression. Virology, 483, 174-184. 
Kulshreshtha, V., Babiuk, L. A., & Tikoo, S. K. (2004). Role of bovine adenovirus-3 33K protein in viral 
replication. Virology, 323(1), 59-69. 
Kulshreshtha, V., & Tikoo, S. K. (2008). Interaction of bovine adenovirus-3 33K protein with other viral 
proteins. Virology, 381(1), 29-35. 
91	
	
Kumar, P., Ayalew, L. E., Godson, D. L., Gaba, A., Babiuk, L. A., & Tikoo, S. K. (2014). Mucosal 
immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine 
herpesvirus-1 gD and bovine IL-6. Vaccine, 32(26), 3300-3306. 
Kurts, C., Robinson, B. W., & Knolle, P. A. (2010). Cross-priming in health and disease. Nature Reviews 
Immunology, 10(6), 403. 
Lanzavecchia, A. (1985). Antigen-specific interaction between T and B cells. Nature, 314(6011), 537. 
Lanzavecchia, A., & Sallusto, F. (2000). Dynamics of T lymphocyte responses: intermediates, effectors, 
and memory cells. Science, 290(5489), 92-97. 
Lanzavecchia, A., & Sallusto, F. (2001). Regulation of T cell immunity by dendritic cells. Cell, 106(3), 
263-266. 
Lanzavecchia, A., & Sallusto, F. (2001). Antigen decoding by T lymphocytes: from synapses to fate 
determination. Nature immunology, 2(6), 487. 
Laskin, D. L. (2009). Macrophages and inflammatory mediators in chemical toxicity: a battle of 
forces. Chemical research in toxicology, 22(8), 1376-1385. 
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011). Macrophages and tissue injury: agents 
of defense or destruction?. Annual review of pharmacology and toxicology, 51, 267-288. 
Lasaro, M. O., & Ertl, H. C. (2004). Human Papillomavirus-associated cervical cancer: prophyllactic and 
therapeutic vaccines. Gene Ther Mol Biol, 8, 291-306. 
Lauvau, G., Chorro, L., Spaulding, E., & Soudja, S. M. H. (2014). Inflammatory monocyte effector 
mechanisms. Cellular immunology, 291(1-2), 32-40. 
LeBien, T. W., & Tedder, T. F. (2008). B lymphocytes: how they develop and function. Blood, 112(5), 
1570-1580. 
Lehmukhul, H. D., Smith, M. H., & Gough, P. M. (1979). Neutralizing antibody to bovine adenovirus 
serotype 3 in healthy cattle and cattle with respiratory tract disease. American journal of veterinary 
research, 40(4), 580-583. 
Lemarchand, P., Jaffe, H. A., Danel, C., Cid, M. C., Kleinman, H. K., Stratford-Perricaudet, L. D., & 
Crystal, R. G. (1992). Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA 
to human endothelial cells. Proceedings of the National Academy of Sciences, 89(14), 6482-6486. 
92	
	
Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E., & Crystal, 
R. G. (2000). Dynein-and microtubule-mediated translocation of adenovirus serotype 5 occurs after 
endosomal lysis. Human gene therapy, 11(1), 151-165. 
Leppard, K. N. (2008). Adenoviruses: Molecular Biology. Encyclopedia of Virology. 
Marek, A., Kaján, G. L., Kosiol, C., Harrach, B., Schlötterer, C., & Hess, M. (2014). Complete genome 
sequences of pigeon adenovirus 1 and duck adenovirus 2 extend the number of species within the genus 
Aviadenovirus. Virology, 462, 107-114. 
Li, J., Faber, M., Papaneri, A., Faber, M. L., McGettigan, J. P., Schnell, M. J., & Dietzschold, B. (2006). 
A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein 
confers protective immunity against rabies in mice. Virology, 356(1-2), 147-154. 
Li, X., Bangari, D. S., Sharma, A., & Mittal, S. K. (2009). Bovine adenovirus serotype 3 utilizes sialic 
acid as a cellular receptor for virus entry. Virology, 392(2), 162-168. 
Lindenbaum, J. O., Field, J., & Hurwitz, J. (1986). The adenovirus DNA binding protein and adenovirus 
DNA polymerase interact to catalyze elongation of primed DNA templates. Journal of Biological 
Chemistry, 261(22), 10218-10227. 
Liu, Q., & Muruve, D. A. (2003). Molecular basis of the inflammatory response to adenovirus 
vectors. Gene therapy, 10(11), 935. 
Liu, Y., Hu, R., Zhang, S., Zhang, F., Li, Z., Wei, X., & Chen, L. (2006). Expression of the Foot-and-
Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 
elicits a humoral antibody response in a porcine model. Viral immunology, 19(2), 202-209. 
Liu, M. A. (2010). Immunologic basis of vaccine vectors. Immunity, 33(4), 504-515. 
Lund, H., Boysen, P., Åkesson, C. P., Lewandowska-Sabat, A. M., & Storset, A. K. (2016). Transient 
migration of large numbers of CD14++ CD16+ monocytes to the draining lymph node after onset of 
inflammation. Frontiers in immunology, 7, 322. 
Lustig, A., A. T. Weeraratna, W. W. Wood, D. Teichberg, D. Bertak, A. Carter, S. Poosala, J. Firman, K. 
G. Becker, A. B. Zonderman, D. L. Longo, and D. D. Taub. (2007). Transcriptome analysis of age-, 
gender-and diet-associated changes in murine thymus. Cell. Immunol. 245, 42–61. 
Lutz, P., & Kedinger, C. (1996). Properties of the adenovirus IVa2 gene product, an effector of late-
phase-dependent activation of the major late promoter. Journal of virology, 70(3), 1396-1405. 
93	
	
Lutz, P., Rosa-Calatrava, M., & Kedinger, C. (1997). The product of the adenovirus intermediate gene IX 
is a transcriptional activator. Journal of virology, 71(7), 5102-5109. 
Lyakh, L. A., Koski, G. K., Young, H. A., Spence, S. E., Cohen, P. A., & Rice, N. R. (2002). Adenovirus 
type 5 vectors induce dendritic cell differentiation in human CD14+ monocytes cultured under serum-free 
conditions. Blood, 99(2), 600-608. 
Madin, S. H., & Darby Jr, N. B. (1958). Established kidney cell lines of normal adult bovine and ovine 
origin. Proceedings of the Society for Experimental Biology and Medicine, 98(3), 574-576. 
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006). Directed evolution of adeno-
associated virus yields enhanced gene delivery vectors. Nature biotechnology, 24(2), 198. 
Makadiya, N., Gaba, A., & Tikoo, S. K. (2015). Cleavage of bovine adenovirus type 3 non-structural 
100K protein by protease is required for nuclear localization in infected cells but is not essential for virus 
replication. Journal of General Virology, 96(9), 2749-2763. 
Martinon, F., Burns, K., & Tschopp, J. (2002). The inflammasome: a molecular platform triggering 
activation of inflammatory caspases and processing of proIL-β. Molecular cell, 10(2), 417-426. 
Martinon, F., Mayor, A., & Tschopp, J. (2009). The inflammasomes: guardians of the body. Annual 
review of immunology, 27, 229-265. 
Mast, T. C., Kierstead, L., Gupta, S. B., Nikas, A. A., Kallas, E. G., Novitsky, V., & Wolfe, N. D. (2010). 
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 
neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine 
trials. Vaccine, 28(4), 950-957. 
Meier, O., & Greber, U. F. (2004). Adenovirus endocytosis. The journal of gene medicine, 6(S1). 
Meyer, E. H., DeKruyff, R. H., & Umetsu, D. T. (2008). T cells and NKT cells in the pathogenesis of 
asthma. Annu. Rev. Med., 59, 281-292. 
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. 
(2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C 
virus. Nature, 437(7062), 1167. 
Milne, C. D., & Paige, C. J. (2006). IL-7: a key regulator of B lymphopoiesis. In Seminars in 
immunology (Vol. 18, No. 1, pp. 20-30). Academic Press. 
94	
	
Mir, M. (2015). Introduction to costimulation and costimulatory molecules. In Developing Costimulatory 
Molecules for Immunotherapy of Diseases (pp. 1-43). Academic press.  
Molinier-Frenkel, V., Gahery-Segard, H., Mehtali, M., Le Boulaire, C., Ribault, S., Boulanger, P., & 
Farace, F. (2000). Immune response to recombinant adenovirus in humans: capsid components from viral 
input are targets for vector-specific cytotoxic T lymphocytes. Journal of virology, 74(16), 7678-7682. 
Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S. S., Choppin, J., Gahery-Ségard, H., & Guillet, J. 
G. (2002). Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune 
response. Journal of virology, 76(1), 127-135. 
Moll, H., Fuchs, H., Blank, C., & Röllinghoff, M. (1993). Langerhans cells transport Leishmania major 
from the infected skin to the draining lymph node for presentation to antigen-specific T cells. European 
journal of immunology, 23(7), 1595-1601. 
Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nature 
reviews immunology, 8(12), 958. 
Mossman, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986). Two types of 
murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted 
proteins. The Journal of immunology, 136(7), 2348-2357. 
Mul, Y. M., Verrijzer, C. P., & Van der Vliet, P. C. (1990). Transcription factors NFI and NFIII/oct-1 
function independently, employing different mechanisms to enhance adenovirus DNA 
replication. Journal of virology, 64(11), 5510-5518. 
Murphy, K., & Weaver, C. (2016). Janeway's immunobiology. Garland Science. 
Nagata, K., Guggenheimer, R. A., & Hurwitz, J. (1983). Specific binding of a cellular DNA replication 
protein to the origin of replication of adenovirus DNA. Proceedings of the National Academy of 
Sciences, 80(20), 6177-6181. 
Nutt, S. L., & Kee, B. L. (2007). The transcriptional regulation of B cell lineage 
commitment. Immunity, 26(6), 715-725. 
Oettgen, H. C. (2000). Regulation of the IgE isotype switch: new insights on cytokine signals and the 
functions of ε germline transcripts. Current opinion in immunology, 12(6), 618-623. 
Osugi, Y., Vuckovic, S., & Hart, D. N. (2002). Myeloid blood CD11c+ dendritic cells and monocyte-
derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood, 100(8), 2858-2866. 
95	
	
Othman, M., Labelle, A., Mazzetti, I., Elbatarny, H. S., & Lillicrap, D. (2007). Adenovirus-induced 
thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet 
clearance. Blood, 109(7), 2832-2839. 
Palucka, K., & Banchereau, J. (1999). Linking innate and adaptive immunity. Nature medicine, 5(8), 868. 
Pancer, Z., & Cooper, M. D. (2006). The evolution of adaptive immunity. Annu. Rev. Immunol., 24, 497-
518. 
Pang, D. J., Neves, J. F., Sumaria, N., & Pennington, D. J. (2012). Understanding the complexity of γδ T-
cell subsets in mouse and human. Immunology, 136(3), 283-290. 
Pardo-Mateos, A., & Young, C. S. H. (2004). Adenovirus IVa2 protein plays an important role in 
transcription from the major late promoter in vivo. Virology, 327(1), 50-59. 
Paterson, C. P. (2010). Molecular characterization of 52K protein of bovine adenovirus type 3 (Doctoral 
dissertation). University of Saskatchewan, Saskatoon, Canada. 
Paterson, C. P., Ayalew, L. E., & Tikoo, S. K. (2012). Mapping of nuclear import signal and importin α3 
binding regions of 52K protein of bovine adenovirus-3. Virology, 432(1), 63-72. 
Peled, J. U., Kuang, F. L., Iglesias-Ussel, M. D., Roa, S., Kalis, S. L., Goodman, M. F., & Scharff, M. D. 
(2008). The biochemistry of somatic hypermutation. Annu. Rev. Immunol., 26, 481-511. 
Pinchuk, L. M., Boyd, B. L., Kruger, E. F., Roditi, I., & Furger, A. (2003). Bovine dendritic cells 
generated from monocytes and bone marrow progenitors regulate immunoglobulin production in 
peripheral blood B cells. Comparative immunology, microbiology and infectious diseases, 26(4), 233-
249. 
Pitcovski, J., Mualem, M., Rei-Koren, Z., Krispel, S., Shmueli, E., Peretz, Y., & Goldberg, D. (1998). 
The complete DNA sequence and genome organization of the avian adenovirus, hemorrhagic enteritis 
virus. Virology, 249(2), 307-315. 
Proffitt, J. L., Sharma, E., & Blair, G. E. (1994). Adenovirus 12-mediated down-regulation of the major 
histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element 
responsive to Ad12 E1A. Nucleic acids research, 22(22), 4779-4788. 
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G., Dörner, T., & Hiepe, F. (2006). 
Competence and competition: the challenge of becoming a long-lived plasma cell. Nature Reviews 
Immunology, 6(10), 741. 
96	
	
Randall, R. E., & Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, 
signalling, antiviral responses and virus countermeasures. Journal of General Virology, 89(1), 1-47. 
Randolph, G. J., Jakubzick, C., & Qu, C. (2008). Antigen presentation by monocytes and monocyte-
derived cells. Current opinion in immunology, 20(1), 52-60. 
Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G. P., & Batshaw, M. L. (2003). Fatal 
systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following 
adenoviral gene transfer. Molecular genetics and metabolism, 80(1), 148-158. 
Rasmussen, U. B., Benchaibi, M., Meyer, V., Schlesinger, Y., & Schughart, K. (1999). Novel human 
gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived 
cells. Human gene therapy, 10(16), 2587-2599. 
Reddy, P. S., Idamakanti, N., Zakhartchouk, A. N., Baxi, M. K., Lee, J. B., Pyne, C., Babiuk, L. & Tikoo, 
S. K. (1998). Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 
3. Journal of virology, 72(2), 1394-1402. 
Reddy, P. S., Idamakanti, N., Zakhartchouk, L. N., Babiuk, L. A., Mehtali, M., & Tikoo, S. K. (2000). 
Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine 
adenovirus-3. Virus research, 70(1-2), 65-73. 
Reddy, P. S., Idamakanti, N., Pyne, C., Zakhartchouk, A. N., Godson, D. L., Papp, Z., & Tikoo, S. K. 
(2000). The immunogenicity and efficacy of replication-defective and replication-competent bovine 
adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. Veterinary immunology and 
immunopathology, 76(3-4), 257-268. 
Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T., & Jenkins, M. K. (2001). Visualizing the generation of 
memory CD4 T cells in the whole body. Nature, 410(6824), 101. 
Reizis, B., Colonna, M., Trinchieri, G., Barrat, F., & Gilliet, M. (2011). Plasmacytoid dendritic cells: one-
trick ponies or workhorses of the immune system?. Nature Reviews Immunology, 11(8), 558. 
Renjifo, X., Howard, C., Kerkhofs, P., Denis, M., Urbain, J., Moser, M., & Pastoret, P. P. (1997). 
Purification and characterization of bovine dendritic cells from peripheral blood. Veterinary immunology 
and immunopathology, 60(1-2), 77-88. 
Rhodes, S. G., Hewinson, R. G., & Vordermeier, H. M. (2001). Antigen recognition and 
immunomodulation by γδ T cells in bovine tuberculosis. The Journal of Immunology, 166(9), 5604-5610. 
97	
	
Richards, S., Watanabe, C., Santos, L., Craxton, A., & Clark, E. A. (2008). Regulation of B-cell entry into 
the cell cycle. Immunological reviews, 224(1), 183-200. 
Rollier, C. S., Reyes-Sandoval, A., Cottingham, M. G., Ewer, K., & Hill, A. V. (2011). Viral vectors as 
vaccine platforms: deployment in sight. Current opinion in immunology, 23(3), 377-382. 
Romagnani, S. (1994). Lymphokine production by human T cells in disease states. Annual review of 
immunology, 12(1), 227-257. 
Rosa-Calatrava, M., Grave, L., Puvion-Dutilleul, F., Chatton, B., & Kedinger, C. (2001). Functional 
analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, 
and nuclear reorganization. Journal of virology, 75(15), 7131-7141. 
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., & 
Perricaudet, M. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance 
regulator gene to the airway epithelium. Cell, 68(1), 143-155. 
Roshtkhari, F., Mohammadi, G., & Mayameei, A. (2012). Serological evaluation of relationship between 
viral pathogens (BHV-1, BVDV, BRSV, PI-3V, and Adeno3) and dairy calf pneumonia by indirect 
ELISA. Tropical animal health and production, 44(5), 1105-1110. 
Rowe, W. P., Hartley, J. W., & Huebner, R. J. (1956). Additional serotypes of the APC virus group. 
Proceedings of the Society for Experimental Biology and Medicine, 91(2), 260-262. 
Rowe, W., Huebner, R., Gilmore, L. K., Parrott, R., & Ward, T. (1953). Isolation of a Cytopathogenic 
Agent from Human Adenoids undergoing Spontaneous Degeneration in Tissue Culture. Proceedings of 
the Society for Experimental Biology and Medicine, 84(3), 570-73. 
Ruigrok, R. W., Barge, A., Mittal, S. K., & Jacrot, B. (1994). The fibre of bovine adenovirus type 3 is 
very long but bent. Journal of general virology, 75(8), 2069-2073. 
Russell, W. C., & Precious, B. (1982). Nucleic acid-binding properties of adenovirus structural 
polypeptides. Journal of General Virology, 63(1), 69-79. 
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and 
the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II 
compartment: downregulation by cytokines and bacterial products. Journal of Experimental 
Medicine, 182(2), 389-400. 
98	
	
Sansom, D. M., Manzotti, C. N., & Zheng, Y. (2003). What's the difference between CD80 and 
CD86?. Trends in immunology, 24(6), 313-318. 
Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., & Melief, C. J. (1998). T-cell help for 
cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature, 393(6684), 480. 
Schuler, G., & Steinman, R. M. (1985). Murine epidermal Langerhans cells mature into potent 
immunostimulatory dendritic cells in vitro. Journal of Experimental Medicine, 161(3), 526-546. 
Segerman, A., Lindman, K., Mei, Y. F., Allard, A., & Wadell, G. (2006). Adenovirus types 11p and 35 
attach to and infect primary lymphocytes and monocytes, but hexon expression in T-cells requires prior 
activation. Virology, 349(1), 96-111. 
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008). Monocyte-mediated defense against 
microbial pathogens. Annu. Rev. Immunol., 26, 421-452. 
Sester, M., Koebernick, K., Owen, D., Ao, M., Bromberg, Y., May, E., & Steinle, A. (2010). Conserved 
amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I 
and MICA/B proteins. The journal of immunology, 184(1), 255-267. 
Sharma, A., Li, X., Bangari, D. S., & Mittal, S. K. (2009). Adenovirus receptors and their implications in 
gene delivery. Virus research, 143(2), 184-194. 
Shayakhmetov, D. M., Eberly, A. M., Li, Z. Y., & Lieber, A. (2005). Deletion of penton RGD motifs 
affects the efficiency of both the internalization and the endosome escape of viral particles containing 
adenovirus serotype 5 or 35 fiber knobs. Journal of virology, 79(2), 1053-1061. 
Shenk, T., & Flint, J. (1991). Transcriptional and transforming activities of the adenovirus E1A proteins. 
In Advances in cancer research (Vol. 57, pp. 47-85). Academic Press. 
Shiver, J. W., Fu, T. M., Chen, L., Casimiro, D. R., Davies, M. E., Evans, R. K., & Huang, L. (2002). 
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus 
immunity. Nature, 415(6869), 331. 
Short, J. J., Pereboev, A. V., Kawakami, Y., Vasu, C., Holterman, M. J., & Curiel, D. T. (2004). 
Adenovirus serotype 3 utilizes CD80 (B7. 1) and CD86 (B7. 2) as cellular attachment 
receptors. Virology, 322(2), 349-359. 
Shortman, K., & Liu, Y. J. (2002). Mouse and human dendritic cell subtypes. Nature Reviews 
Immunology, 2(3), 151. 
99	
	
Sibley, S. D., Goldberg, T. L., & Pedersen, J. A. (2011). Detection of known and novel adenoviruses in 
cattle wastes via broad-spectrum primers. Applied and environmental microbiology, 77(14), 5001-5008. 
Smith, T. A., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., & Kaleko, M. 
(1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature 
genetics, 5(4), 397. 
Stahl, P. D. (1992). The mannose receptor and other macrophage lectins. Current opinion in 
immunology, 4(1), 49-52. 
Stavnezer, J., Guikema, J. E., & Schrader, C. E. (2008). Mechanism and regulation of class switch 
recombination. Annu. Rev. Immunol., 26, 261-292. 
Steele, E. J. (2009). Mechanism of somatic hypermutation: critical analysis of strand biased mutation 
signatures at A: T and G: C base pairs. Molecular immunology, 46(3), 305-320. 
Steinman, L. (2007). A brief history of T H 17, the first major revision in the T H 1/T H 2 hypothesis of T 
cell–mediated tissue damage. Nature medicine, 13(2), 139. 
Steinman, R. M., & Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs 
of mice: I. Morphology, quantitation, tissue distribution. Journal of Experimental Medicine, 137(5), 
1142-1162. 
Steinman, R. M., & Hemmi, H. (2006). Dendritic cells: translating innate to adaptive immunity. In From 
Innate Immunity to Immunological Memory (pp. 17-58). Springer, Berlin, Heidelberg. 
Stewart, P. L., Fuller, S. D., & Burnett, R. M. (1993). Difference imaging of adenovirus: bridging the 
resolution gap between X-ray crystallography and electron microscopy. The EMBO journal, 12(7), 2589-
2599. 
Stewart, M., Thiel, M., & Hogg, N. (1995). Leukocyte integrins. Current opinion in cell biology, 7(5), 
690-696. 
Stratford-Perricaudet, L. D., Levrero, M., Chasse, J. F., Perricaudet, M., & Briand, P. (1990). Evaluation 
of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus 
vector. Human gene therapy, 1(3), 241-256. 
Strunze, S., Engelke, M. F., Wang, I. H., Puntener, D., Boucke, K., Schleich, S., & Greber, U. F. (2011). 
Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus 
infection. Cell host & microbe, 10(3), 210-223. 
100	
	
Suleymanov, S. M., V. S. Slobodjanik, P. A. Parshin, V. V. Safonov, E. A. Popov, and V. I. Parshinin. 
(2005). The morphology of lymphoid organs and digestive system in young animals under the immune 
status correction. Vet. Pathol. 7, 5–80. 
Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S., & Greber, U. F. (2001). Adenovirus-activated 
PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. The EMBO 
journal, 20(6), 1310-1319. 
Tacke, F., Ginhoux, F., Jakubzick, C., van Rooijen, N., Merad, M., & Randolph, G. J. (2006). Immature 
monocytes acquire antigens from other cells in the bone marrow and present them to T cells after 
maturing in the periphery. Journal of Experimental Medicine, 203(3), 583-597. 
Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., & Ohba, Y. (2007). DAI (DLM-
1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 448(7152), 501. 
Tatsis, N., & Ertl, H. C. (2004). Adenoviruses as vaccine vectors. Molecular Therapy, 10(4), 616-629. 
Tatsis, N., Tesema, L., Robinson, E. R., Giles-Davis, W., McCoy, K., Gao, G. P., & Ertl, H. C. J. (2006). 
Chimpanzee-origin adenovirus vectors as vaccine carriers. Gene therapy, 13(5), 421. 
Täuber, B., & Dobner, T. (2001). Molecular regulation and biological function of adenovirus early genes: 
the E4 ORFs. Gene, 278(1), 1-23. 
Tibbles, L. A., Spurrell, J. C., Bowen, G. P., Liu, Q., Lam, M., Zaiss, A. K., & Muruve, D. A. (2002). 
Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the CXC 
chemokine IP-10. Journal of virology, 76(4), 1559-1568. 
Tiselius, A., & Kabat, E. A. (1938). Electrophoresis of immune serum. Science, 87(2262), 416-417. 
Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., & Wold, W. S. (1996). The 
adenovirus death protein (E3-11.6 K) is required at very late stages of infection for efficient cell lysis and 
release of adenovirus from infected cells. Journal of virology, 70(4), 2296-2306. 
Tollefson, A. E., Kuppuswamy, M., Shashkova, E. V., Doronin, K., & Wold, W. S. (2007). Preparation 
and titration of CsCl-banded adenovirus stocks. In Adenovirus Methods and Protocols (pp. 223-235). 
Humana Press. 
Tomko, R. P., Xu, R., & Philipson, L. (1997). HCAR and MCAR: the human and mouse cellular 
receptors for subgroup C adenoviruses and group B coxsackieviruses. Proceedings of the National 
Academy of Sciences, 94(7), 3352-3356. 
101	
	
Topham, D. J., Tripp, R. A., Hamilton-Easton, A. M., Sarawar, S. R., & Doherty, P. C. (1996). 
Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and 
Ig. The Journal of Immunology, 157(7), 2947-2952. 
Tribouley, C., Lutz, P., Staub, A., & Kedinger, C. (1994). The product of the adenovirus intermediate 
gene IVa2 is a transcriptional activator of the major late promoter. Journal of virology, 68(7), 4450-4457. 
Trinchieri, G. (1989). Biology of natural killer cells. In Advances in immunology (Vol. 47, pp. 187-376). 
Academic Press. 
Trombetta, E. S., & Mellman, I. (2005). Cell biology of antigen processing in vitro and in vivo. Annu. 
Rev. Immunol., 23, 975-1028. 
Tsuchida, T., Zou, J., Saitoh, T., Kumar, H., Abe, T., Matsuura, Y., & Akira, S. (2010). The ubiquitin 
ligase TRIM56 regulates innate immune responses to intracellular double-stranded 
DNA. Immunity, 33(5), 765-776. 
Tucker, P. A., Tsernoglou, D., Tucker, A. D., Coenjaerts, F. E., Leenders, H., & Vliet, P. C. (1994). 
Crystal structure of the adenovirus DNA binding protein reveals a hook-on model for cooperative DNA 
binding. The EMBO journal, 13(13), 2994-3002. 
Turvey, S. E., & Broide, D. H. (2010). Innate immunity. Journal of Allergy and Clinical 
Immunology, 125(2), S24-S32. 
Ullman, A. J., & Hearing, P. (2008). Cellular proteins PML and Daxx mediate an innate antiviral defense 
antagonized by the adenovirus E4 ORF3 protein. Journal of virology, 82(15), 7325-7335. 
van Breukelen, B., Brenkman, A. B., Holthuizen, P. E., & van der Vliet, P. C. (2003). Adenovirus type 5 
DNA binding protein stimulates binding of DNA polymerase to the replication origin. Journal of 
virology, 77(2), 915-922. 
van Oostrum, J., & Burnett, R. M. (1985). Molecular composition of the adenovirus type 2 
virion. Journal of virology, 56(2), 439-448. 
Varga, M. J., Weibull, C., & Everitt, E. (1991). Infectious entry pathway of adenovirus type 2. Journal of 
virology, 65(11), 6061-6070. 
Veldhoen, M., Uyttenhove, C., Van Snick, J., Helmby, H., Westendorf, A., Buer, J., & Stockinger, B. 
(2008). Transforming growth factor-β'reprograms' the differentiation of T helper 2 cells and promotes an 
interleukin 9–producing subset. Nature immunology, 9(12), 1341. 
102	
	
Velicer, L. F., & Ginsberg, H. S. (1970). Synthesis, transport, and morphogenesis of type 5 adenovirus 
capsid proteins. Journal of virology, 5(3), 338-352. 
Vellinga, J., Van der Heijdt, S., & Hoeben, R. C. (2005). The adenovirus capsid: major progress in minor 
proteins. Journal of General Virology, 86(6), 1581-1588. 
Vellinga, J., van den Wollenberg, D. J., van der Heijdt, S., Rabelink, M. J., & Hoeben, R. C. (2005). The 
coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and 
thermostability. Journal of virology, 79(5), 3206-3210. 
von Andrian, U. H., & Mackay, C. R. (2000). T-cell function and migration—two sides of the same 
coin. New England Journal of Medicine, 343(14), 1020-1034. 
Vos, Q., Lees, A., Wu, Z. Q., Snapper, C. M., & Mond, J. J. (2000). B-cell activation by T-cell-
independent type 2 antigens as an integral part of the humoral immune response to pathogenic 
microorganisms. Immunological reviews, 176, 154-170. 
Vrati, S., Boyle, D., Kocherhans, R., & Both, G. W. (1995). Sequence of ovine adenovirus homologs for 
100K hexon assembly, 33K, pVIII, and fiber genes: early region E3 is not in the expected 
location. Virology, 209(2), 400-408. 
Wang, H., Lee, C. H., Qi, C., Tailor, P., Feng, J., Abbasi, S., & Morse, H. C. (2008). IRF8 regulates B-
cell lineage specification, commitment, and differentiation. Blood, 112(10), 4028-4038. 
Wickham, T. J. (2002). Genetic targeting of adenoviral vectors. Vector Targeting for Therapeutic Gene 
Delivery, 143-170.  
Wickham, T. J., Filardo, E. J., Cheresh, D. A., & Nemerow, G. R. (1994). Integrin alpha v beta 5 
selectively promotes adenovirus mediated cell membrane permeabilization. The Journal of cell 
biology, 127(1), 257-264. 
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993). Integrins αvβ3 and αvβ5 
promote adenovirus internalization but not virus attachment. Cell, 73(2), 309-319. 
Wiethoff, C. M., Wodrich, H., Gerace, L., & Nemerow, G. R. (2005). Adenovirus protein VI mediates 
membrane disruption following capsid disassembly. Journal of virology, 79(4), 1992-2000. 
Wilson, J. M. (1996). Adenoviruses as gene-delivery vehicles. New England Journal of 
Medicine, 334(18), 1185-1187. 
103	
	
Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., & Ricciardi-Castagnoli, P. 
(1997). Maturation stages of mouse dendritic cells in growth factor–dependent long-term 
cultures. Journal of Experimental Medicine, 185(2), 317-328. 
Witmer, M. D., & Steinman, R. M. (1984). The anatomy of peripheral lymphoid organs with emphasis on 
accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's 
patch. American journal of anatomy, 170(3), 465-481. 
Witmer-Pack, M. D., Hughes, D. A., Schuler, G., Lawson, L., McWilliam, A., Inaba, K., & Gordon, S. 
(1993). Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. Journal of 
Cell Science, 104(4), 1021-1029. 
Wold, W. S. M., Tollefson, A. E., & Hermiston, T. W. (1995). E3 transcription unit of adenovirus. In The 
Molecular Repertoire of Adenoviruses I (pp. 237-274). Springer, Berlin, Heidelberg. 
Wold, W. S., & Gooding, L. R. (1991). Region E3 of adenovirus: a cassette of genes involved in host 
immunosurveillance and virus-cell interactions. Virology, 184(1), 1-8. 
Wong, K. L., Tai, J. J. Y., Wong, W. C., Han, H., Sem, X., Yeap, W. H., & Wong, S. C. (2011). Gene 
expression profiling reveals the defining features of the classical, intermediate and nonclassical human 
monocyte subsets. Blood, blood-2010. 
Wong, K. L., Yeap, W. H., Tai, J. J. Y., Ong, S. M., Dang, T. M., & Wong, S. C. (2012). The three 
human monocyte subsets: implications for health and disease. Immunologic research, 53(1-3), 41-57. 
Wu, Q., & Tikoo, S. K. (2004). Altered tropism of recombinant bovine adenovirus type-3 expressing 
chimeric fiber. Virus research, 99(1), 9-15. 
Wu, H., Seki, T., Dmitriev, I., Uil, T., Kashentseva, E., Han, T., & Curiel, D. T. (2002). Double 
modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus–adenovirus 
receptor-independent gene transfer efficiency. Human gene therapy, 13(13), 1647-1653. 
Xiang, Z. Q., Yang, Y., Wilson, J. M., & Ertl, H. C. (1996). A replication-defective human adenovirus 
recombinant serves as a highly efficacious vaccine carrier. Virology, 219(1), 220-227. 
Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M., & Ertl, H. C. J. (2003). Oral 
vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine 
carrier. Journal of virology, 77(20), 10780-10789. 
104	
	
Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008). A regulatory B 
cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory 
responses. Immunity, 28(5), 639-650. 
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995). Cellular and humoral immune responses to viral 
antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. Journal of 
virology, 69(4), 2004-2015. 
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., & Fujita, T. 
(2004). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate 
antiviral responses. Nature immunology, 5(7), 730. 
Zaiss, A. K., Machado, H. B., & Herschman, H. R. (2009). The influence of innate and pre-existing 
immunity on adenovirus therapy. Journal of cellular biochemistry, 108(4), 778-790. 
Zakhartchouk, A. N., Reddy, P. S., Baxi, M., Baca-Estrada, M. E., Mehtali, M., Babiuk, L. A., & Tikoo, 
S. K. (1998). Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-
length and truncated form of bovine herpesvirus type 1 glycoprotein gD. Virology, 250(1), 220-229. 
Zakhartchouk, A. N., Pyne, C., Mutwiri, G. K., Papp, Z., Baca-Estrada, M. E., Griebel, P., & Tikoo, S. K. 
(1999). Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective 
immunity to bovine herpesvirus-1. Journal of General Virology, 80(5), 1263-1269. 
Zakhartchouk, A., Connors, W., Van Kessel, A., & Tikoo, S. K. (2004). Bovine adenovirus type 3 
containing heterologous protein in the C-terminus of minor capsid protein IX. Virology, 320(2), 291-300. 
Zawada, A. M., Rogacev, K. S., Rotter, B., Winter, P., Marell, R. R., Fliser, D., & Heine, G. H. (2011). 
SuperSAGE evidence for CD14++ CD16+ monocytes as a third monocyte subset. Blood, blood-2011. 
Ziegler-Heitbrock, H. W. L. (1996). Heterogeneity of human blood monocytes: the CD14+ CD16+ 
subpopulation. Immunology today, 17(9), 424-428. 
Ziegler-Heitbrock, L. (2007). The CD14+ CD16+ blood monocytes: their role in infection and 
inflammation. Journal of leukocyte biology, 81(3), 584-592. 
Zhang, W., & Imperiale, M. J. (2003). Requirement of the adenovirus IVa2 protein for virus 
assembly. Journal of virology, 77(6), 3586-3594. 
105	
	
Zhang, Y., Chirmule, N., Gao, G. P., Qian, R., Croyle, M., Joshi, B., & Wilson, J. M. (2001). Acute 
cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and 
macrophages. Molecular Therapy, 3(5), 697-707. 
Zhang, X., & Mosser, D. M. (2008). Macrophage activation by endogenous danger signals. The Journal 
of pathology, 214(2), 161-178. 
Zhao, X., & Tikoo, S. K. (2016). Deletion of pV affects integrity of capsid causing defect in the 
infectivity of bovine adenovirus-3. Journal of General Virology, 97(10), 2657-2667. 
Ziff, E. B., & Evans, R. M. (1978). Coincidence of the promoter and capped 5′ terminus of RNA from the 
adenovirus 2 major late transcription unit. Cell, 15(4), 1463-1475. 
Zinkernagel, R. M. (1996). Immunology taught by viruses. Science, 271(5246), 173-178. 
